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3Abstract
Standard two-dimensional (2D) in vitro cell culture systems do not mimic the 
complexity found in the liver as three-dimensional (3D) cell-cell and cell-matrix 
interactions are missing. Although the concept of cell culturing was established over 
100 years ago the currently used culture techniques are not yet ideal. In the field 
of pharmacy especially, the need of physiologically-relevant models to characterize 
biotransformation pathways during drug development is urgent. Hepatocytes, the 
main cell type of the liver, are essential components in these in vitro models. Liver 
cell lines and derivation of hepatocyte-like cells from stem cells are alternative 
sources to primary isolations for obtaining hepatocytes.
In the liver, hepatocytes are in continuous interaction with other cells and 
surrounding extracellular matrix (ECM). Moreover, liver functions are strictly 
dependent on correct tissue architecture. One approach to improve the standard 
cell culture systems is to mimic the hepatocytes’ natural microenvironment and 
organization by culturing the cells within biomaterial matrices. Matrix-based culture 
systems for hepatocytes have been developed from natural, synthetic and hybrid 
biomaterials and the cells can be grown in 2D or 3D configuration. The aim of this 
thesis was to find new defined culture matrices for in vitro hepatic differentiation.
First, we studied two biomaterials, nanofibrillar cellulose (NFC) hydrogel and 
hyaluronic acid-gelatin (HG) hydrogel, to construct functional liver 3D organoids. 
Both of the studied hydrogels supported 3D spheroid organization of human liver 
progenitor HepaRG cells and their functional polarization. The 3D culture systems 
promoted hepatic differentiation of progenitor cells faster than the standard 2D 
culture. However, the 3D hydrogels did not enhance hepatocyte-like properties 
if the HepaRG cells were pre-differentiated to hepatocyte-like cells in advance. 
Subsequently, we showed that NFC hydrogel culture can be combined with high-
resolution imaging since the intact spheroids can be enzymatically released from 
the matrix. This was not possible with the HG hydrogel. We demonstrated that silica 
bioreplication preserved the 3D spheroid structure with its fine details and cellular 
antigens and allowed detailed morphological analysis of the spheroids cultured in 
NFC hydrogel.
Next, we developed a xeno-free matrix for hepatic specification of human 
pluripotent stem cell-derived definite endoderm (DE) cells using a three-step 
approach. We first proved our hypothesis that a liver progenitor-like matrix, 
HepaRG-derived acellular matrix (ACM), supports hepatic lineage differentiation 
of DE cells. Then, we characterized the ECM proteins secreted by HepaRG cells, 
and finally we showed that the identified proteins, laminin-511 and laminin-521, 
can replicate the effect of HepaRG-ACM. The human pluripotent stem cell-derived 
hepatic cells expressed mature hepatocyte-like functions but the phenotype of the 
cells was eventually closer to fetal hepatocytes than mature cells. Thus, hepatic 
maturation should be further studied. In conclusion, this thesis describes new 
biomaterials for hepatic differentiation, a protocol to form 3D spheroids and to 
transfer intact spheroids to high-resolution imaging, and that the described three-
step approach can guide the identification of new defined matrices.
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2D  Two-dimensional
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NR3C1   Nuclear receptor subfamily 3 group C member 1, also known as 
  glucocorticoid receptor (GR)
OCT4   Octamer-binding transcription factor 4 
OSM   Oncostatin M  
PCL  Poly-ε-caprolactone
PEG  Polyethylene glycol
PEGDA  Polyethylene glycol diacrylate 
PFA  Paraformaldehyde 
PT  Portal triad
qPCR   Quantitative polymerase chain reaction 
RGDS  Arginine-glycine-asparagine-serine
rhEGF   Recombinant human epidermal growth factor 
RNA  Ribonucleic acid
RT-PCR Real time polymerase chain reaction
SBR  Silica bioreplication
SEM  Scanning electron microscopy 
SSEA   Stage-specific embryonic antigen 
TMOS  Tetraethyl orthosilicate 
Wnt   Wingless type
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1 Introduction
The approximated cost of bringing a new molecular entity, a novel drug, to a market 
is 1.8 billion US dollars, and is constantly rising (Paul et al. 2010). Only over 10 
years ago the respective price was estimated to be 0.8 billion US dollars (Dickson 
and Gagnon 2004). The high costs are primarily due to high failure related to 
unaccepted efficacy (56%) and toxicity in human (28%) (Arrowsmith and Miller 
2013). Currently less than one in ten drugs that enter into the clinical phase will 
eventually get market approval (M. Hay et al. 2014). Additionally, withdrawals from 
the market are still seen: 19 drugs were withdrawn in the EU during 2002-2011 
(McNaughton et al. 2014). For economic and regulatory reasons, the researchers 
in the academia and industry are evermore looking for tools to better predict the 
effects of new molecules in humans (LeCluyse et al. 2012). Importantly, in 21% of 
the cases hepatic disorders was the reason for withdrawn drugs in the EU in 2002-
2011 (McNaughton et al. 2014). 
Currently, there are satisfactory pharmacokinetic in vitro models to study 
induction and inhibition of liver enzymes and many assays have been proposed for 
studying hepatotoxicity (LeCluyse et al. 2012). However, there is an urgent need 
for advanced physiologically-relevant models to characterize biotransformation 
pathways. Hepatocytes, the main cell type of the liver, are essential components 
in these in vitro models. Subcellular systems such as liver microsomes can be 
exploited for metabolic profiling but only living cells can replicate all the metabolic 
processes occurring in vivo (Guillouzo and Guguen-Guillouzo 2008; A.P. Li 
2007). Viable hepatocytes can be isolated from human liver, and they continue to 
serve the golden standard cell type for in vitro tests even though there are certain 
limitations in their use (Guillouzo and Guguen-Guillouzo 2008; FDA 2012). 
One of the reasons hampering their use is their limited life-span in culture. To 
overcome this, significant improvements in maintaining their phenotype have 
been achieved when using in vivo mimicking culture matrices (Bissell et al. 1987; 
Michalopoulos and Pitot 1975; Uygun et al. 2010; Sellaro et al. 2010). Alternative 
source for obtaining viable human hepatocytes are human pluripotent stem cells 
(hPSC). Both human embryonic stem cells (hESC) and human induced pluripotent 
stem cells (hiPSC) have the ability to form any cell type of the human body 
(Thomson et al. 1998; Yu et al. 2007; K. Takahashi et al. 2007) and thus they are 
broadly studied for various biomedical applications, as well as for drug testing. 
The concept of culturing cells was established over 100 years ago but the currently 
used culture techniques are not yet ideal. Cell culturing can be seen to have started 
in 1885 when cells were kept alive outside a body for a few days (Wall 2015). In 
1907 cells were successfully grown in a laboratory for the first time (Harrison et al. 
1907). Thereafter, numerous cell culture systems, reagents, and devices have been 
reported. Still, cell cultures are routinely performed with very simple techniques 
in two-dimensional (2D) configuration (Breslin and O’Driscoll 2013). Standard 2D 
monolayer cultures on flat, typically plastic surfaces do not simulate the complexity 
found in in vivo tissue as cell-matrix and multidimensional cell-cell interactions are 
missing (Owen and Shoichet 2010; Breslin and O’Driscoll 2013). Mimicking the cells’ 
natural microenvironment, extracellular matrix (ECM), in vitro with biomaterials 
has been shown to be a successful strategy to improve tissue-like functions of the 
13
cultured cells (Tibbitt and Anseth 2009; Breslin and O’Driscoll 2013; Owen and 
Shoichet 2010). Development of bioinspired materials has two approaches. The 
materials are either extracted or derived from nature and then modified, or the idea 
for a new material is from nature but the product is manufactured synthetically 
(Smitthipong et al. 2014). Thus, bioinspired materials can be classified as materials 
originating from nature or materials mimicking the nature. Developing liver 
mimicking culture systems for hepatocytes should start by learning from the liver. 
The shifting trend from the standard 2D cultures to more advanced systems, 
often using the third culture dimension, challenges the basic analysis techniques. 
In more complex culture formats visualization of the sample or data collection 
can be problematic. For example, in microfluidic devices the cell number 
and the culture volume can be so low that detection of an analyte can cause 
issues, or in case of three-dimensional (3D) culture system, the matrix or a 
thick sample itself can hinder microscoping of the specimen (Pampaloni et al. 
2007; Esch et al. 2015). Consequently, it is important that the innovations in 
analysis techniques keep up with the development of advanced culture systems. 
This thesis describes first structure, functions, development, and ECM proteins 
of the liver and reviews matrix-based cell culture systems for hepatocytes. After the 
literature review, the aims and materials and methods of this thesis are introduced. 
Finally, the obtained results are briefly presented and the findings are discussed.
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2 Review of the literature
2.1 Liver tissue environment
During the last decades hepatic research has significantly advanced and increased 
the knowledge in liver structure, function, and hepatic lineage maturation (Abdel-
Misih and Bloomston 2010; Si-Tayeb et al. 2010a; L. Zhang et al. 2008). New 
molecular biology technologies have provided deeper understanding in regulation of 
gene expression, proliferation, cell cycle, and DNA repair in hepatocytes (Si-Tayeb 
et al. 2010a). This chapter gives an overview of the liver anatomy and function, 
development, describes recently proposed hepatic lineage maturation process, and 
illustrates the extracellular matrix chemistry in the liver.
2.1.1 Liver structure and function
In adults, liver is the largest gland and it weighs approximately 1.5 kg comprising 
two to three percent of body weight (Si-Tayeb et al. 2010a). The liver has various 
functions which are strictly dependent on correct liver tissue architecture (Figure 
1A). A liver lobule is the basic architectural unit consisting of plates of hepatocytes 
with thickness of one to two cells (Schiff, et al. 2011; Si-Tayeb et al. 2010a). The 
hexagonal-shaped lobule is lined by a portal triad vessels composed of portal vein, 
bile duct, and hepatic artery (Figure 1B, D). The portal vein and hepatic artery 
supply blood to the lobule from each of the lobule’s six corners and a network of 
sinusoidal capillaries carry the oxygen and nutrients to a central vein in the middle 
of the lobule. Indeed, a highly vascularized liver receives more blood than any other 
organ in the body (Abdel-Misih and Bloomston 2010). The periportal area close to 
the portal triad is also called zone 1 and the pericentral area next to the central vein 
is called zone 3.
Hepatocytes are the major cell type in the liver representing approximately 
80% of the liver volume and 60% of all liver cells (Malarkey et al. 2005). These 
polyhedral-shaped cells are highly polarized, having a specialized canalicular region 
at their apical membrane and plenty of microvilli on the basolateral surface towards 
the space of Disse, the area between the hepatocytes and sinusoidal endothelial 
cells (Schiff et al. 2011). The canalicular regions of two neighboring hepatocytes are 
connected with tight junctions and form bile canaliculi that drains to the bile duct. 
Hepatocytes are responsible for most of the liver’s biosynthesis and biomolecules’ 
storage functions (Juza and Pauli 2014). They exhibit functional gradients over the 
lobule from zone 1 to zone 3 (Malarkey et al. 2005) (Figure 1C). Hepatocytes in 
zone 1, also called periportal hepatocytes, receive abundant blood supply rich in 
oxygen and nutrients and thus show higher activity in gluconeogenesis, amino acid 
catabolism, ureagenesis, cholesterol synthesis, and bile acid secretion compared to 
the cells close to the central vein, also called  centrilobular cells (Malarkey et al. 
2005; Schiff et al. 2011). In zone 3, the hepatocytes are responsible for glycolysis, 
lipogenesis, and biotransformation of endogenous and exogenous compounds.
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In addition to hepatocytes, at least 14 other cells types can be found in a normal 
liver (Malarkey et al. 2005). Out of these, cholangiocytes, endothelial and sinusoidal 
endothelial cells, Kupffer cells, and hepatic stellate cells are closely cooperating with 
hepatocytes (Si-Tayeb et al. 2010a). Cholangiocytes, also called biliary epithelial 
cells, transport bile and maintain its pH (Tietz and Larusso 2006). Kupffer cells are 
liver macrophages with immunological and phagocytic functions and reside in the 
sinusoidal vessels (Malarkey et al. 2005; Schiff et al. 2011; Si-Tayeb et al. 2010a). 
Hepatic stellate cells, located in the spaces of Disse, are normally quiescent but when 
activated by various cytokines they function as the principal hepatic fibroblasts 
(Malarkey et al. 2005;  Schiff et al. 2011; Martinez-Hernandez and Amenta 1995).
Figure 1  Architecture of the liver. A) The main cell type of the liver are hepatocytes 
which are organized in plates between portal triad and central vein. B) A liver lobule, the 
smallest architectural unit of the liver, is lined by portal triads. C) The hepatocytes exhibit 
functional gradients over the lobule from portal triad (PT), zone 1, to central vein (CV), zone 
3. D) The portal triad is composed of portal vein (PV), hepatic artery (HA), and bile duct 
(B). Picture A is modified from Si-Tayeb et al. 2010a, picture B is inspired by LeCluyse et al. 
2012, and pictures C and D are from hematoxylin and eosin stained human liver sections 
(Lou et al. unpublished).
B
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2.1.2 Embryonic liver development and intrahepatic lineage maturation
Processes occurring during liver development can be categorized into two main 
chains of events: differentiation of all the cell types in liver from their embryonic 
progenitors and the arrangement of the derived cells into highly organized structures 
(Zong and Friedman 2014). In human, gastrulation takes place on approximately 
day 16 of gestation, after which the embryo is composed of ectodermal, mesodermal 
and endodermal germ layers. Liver epithelial cells, hepatocytes and cholangiocytes, 
are derived from the endoderm which also gives rise to pancreas, lung, thyroid, and 
gastrointestinal tract. The next step in liver development is hepatic specification 
during which developing cardiac mesoderm and the septum transversum 
mesenchyme secrete inductive signals, fibroblast growth factor (FGF) and bone 
morphogenic proteins (BMPs), to endoderm cells that differentiate to hepatoblasts 
(Gualdi et al. 1996; Zong and Friedman 2014). 
The formed hepatoblasts are proliferating and form a liver bud, anatomical 
outgrowth from the ventral wall of the foregut endoderm (Zhao and Duncan 2005). 
Immediately after the bud being formed, endothelial cells or angioblasts envelop the 
bud and play important role in the bud’s expansion and separate it from the septum 
transversum mesenchyme (Matsumoto et al 2001; Zhao and Duncan 2005). Next, 
the hepatoblasts begin to invade into surrounding septum transversum mesenchyme 
as cords, and simultaneously, the hepatic vasculature is being developed. The 
hepatoblast population is rapidly proliferating and as a bipotent cell type they 
differentiate into hepatocytic and cholangiocytic lineages (Schiff et al. 2011; Cardinale 
et al. 2011). In concert, other liver cell types are being differentiated, biliary tract is 
developed, and the ECM is formed (Zhao and Duncan 2005). 
Multiple transcription factors, including hepatocyte nuclear factors (HNFs), have 
shown to be crucial for the hepatocyte differentiation (Zhao and Duncan 2005). 
In addition, oncostatin M (OSM), secreted by hematopoietic cells, is essential in 
controlling the late stage hepatocyte differentiation. The maturation of functional 
hepatocytes is gradual and also continues after birth. During fetal and neonatal 
periods, the metabolizing enzyme and transporter expressions occur in several 
patterns and vary for each enzyme subfamily and isoform (Moscovitz and Aleksunes 
2013). The ECM proteins present in the liver are discussed below in chapter 2.1.3. At 
birth, the liver comprises approximately four percent of the newborn’s body weight 
(Suchy 2014). 
In a healthy adult liver, hepatocytes are proliferatively quiescent and their estimated 
life-span is over one year (Roskams 2006; Sell 2001). However, in the case of partial 
hepatectomy, surgical removal of liver mass, or in acute injury the lost liver mass is 
rapidly replaced although the native liver architecture is not reconstituted (Fausto 
and Campbell 2003). The liver has enormous regenerative capacity but results from 
studies on how liver regeneration occurs have been controversial. It has been shown 
that after a partial hepatectomy, hepatocytes resting at G0 phase re-enter the cell-
cycle and start to replicate (Taub 2004). However, after toxin-mediated injuries 
hepatocytes have decreased capacity to proliferate. Some of the findings support 
the assumption that liver stem/progenitor cells (LPCs) participate in repopulating 
the liver after a severe injury in concert with proliferating hepatocytes (Forbes et al. 
2002). In addition, a recent study reported that hepatocytes can be converted into 
cholangiocytes in vivo which might play a role in restoring functions and architecture 
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of the liver after injuries (Yanger et al. 2013).
The research on liver stem cells does not have explicit history. The early observations 
and speculations on LPCs were made before the 19th century and the characterization 
of oval cells, small epithelial cells with oval nuclei, in the 1950s started their broad 
examination (Fausto and Campbell 2003; Farber 1956). LPCs are classified as cells 
that have the ability to differentiate into hepatocytes and cholangiocytes during liver 
regeneration and cellular turnover (Tanimizu and Mitaka 2014). Even though the 
role and origin of LPCs is still not unambiguous their importance in liver biology 
has been proven (Forbes et al. 2002). The LPCs have been suggested to derive from 
periductular cells, hematopoietic stem cells, or the quiescent hepatocytes themselves 
have been suggested to be the stem cells of the liver as their differentiation can be 
activated (Fausto and Campbell 2003; Sell 2001; Y. Zhang et al. 2003). Later, Reid 
and co-workers have reported that both hepatic stem cells and hepatic progenitors 
are found in liver of all donor ages (L. Zhang et al. 2008; Turner et al. 2011; Cardinale 
et al. 2011). 
The stem cells are located in a unique microenvironment called a niche which 
regulates self-renewal and differentiation of the stem cells (Scadden 2006). In 
pediatric and adult livers, the hepatic stem cell niches are found in canals of Hering 
and within the biliary tree (Theise et al. 1999; Kuwahara et al. 2008; Turner et al. 
2011). It has been recently shown that peribiliary glands throughout the biliary tree 
host multipotent stem/progenitor cells which give rise to cholangiocytes, hepatocytes 
and pancreatic committed progenitors (Cardinale et al. 2011; Y. Wang et al. 2013). 
These biliary tree stem/progenitor cells express typical endodermal markers but only 
low-levels or no lineage markers of liver or endocrine pancreas (Cardinale et al. 2011). 
Whether the liver is a classical stem cell lineage system or not is a divisive question 
in the field of hepatology (Sigal et al. 1992; Fausto and Campbell 2003). Intrahepatic 
lineage maturation, as suggested by Reid and co-workers, consists of eight stages 
proceeding from zone 1 to zone 3 in the liver lobule (Turner et al. 2011; Furth et 
al. 2013) (Figure 2). Multipotent hepatic stem cells represent approximately 0.5-2% 
of the liver cells in donors of all ages (Turner et al. 2011). The hepatic stem cells 
co-express epithelial cell adhesion molecule (EpCAM), neural adhesion molecule 
(NCAM), cytokeratin-19 (CK-19), low levels of albumin (ALB) and very low levels or 
no alpha-fetoprotein (AFP) (L. Zhang et al. 2008; Furth et al. 2013; Schmelzer et al. 
2006). In the next stage, the hepatic stem cells differentiate into hepatoblasts which 
can give rise both to hepatocytic and cholangiocytic lineages. Hepatoblasts express 
intercellular adhesion molecule-1, (ICAM-1), EpCAM, early cytochrome P450s, and 
are highly positive for AFP (Turner et al. 2011; Furth et al. 2013; Schmelzer et al. 
2006). 
Next, the hepatoblasts are committed to hepatic progenitors which, according 
to this classification, are unipotent cells and can differentiate only to hepatocytes 
(Turner et al. 2011). Hepatic progenitors express ALB but lack CK-19 and AFP (L. 
Zhang et al. 2008; Furth et al. 2013). In the liver lobule, they are located in the 
beginning of hepatocyte plates. During the later stages of lineage maturation the 
hepatocytes grow in size, become binucleated, and express mature liver markers such 
as CYP3A4, glutathione S-transferases, and high levels of ALB (Turner et al. 2011; 
Furth et al. 2013). Finally, the apoptotic hepatocytes at zone 3 have been reported to 
produce hepatocyte growth factor that simulates the expansion of stem cells and/or 
progenitors which works as positive loop signaling.
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Figure 2 Hepatic lineage maturation from hepatic stem cells to apoptotic 
hepatocytes is suggested to consist of eight steps (Turner et al. 2011; Furth et al. 
2013). The liver lobule exhibits structural and functional gradients from zone 1 to 
zone 3 (L. Zhang et al. 2008; Y. Wang et al. 2011; Turner et al. 2011; Furth et al. 
2013). AFP, alpha-fetoprotein; ALB, albumin; CK-19, cytokeratin-19; CV, central 
vein; CYP, cytochrome P450 enzyme; EpCAM, epithelial cell adhesion molecule; 
ICAM-1, intercellular adhesion molecule-1; NCAM, neural adhesion molecule; PT, 
portal triad. Figure is modified from Turner et al. 2011 and LeCluyse et al. 2012.
2.1.3 Extracellular matrix chemistry
In liver, hepatocytes are in a continuous intereaction with an ECM. The ECM is a 
mixture of molecules which by their structure and function provide essential cues 
for cell proliferation, migration and differentiation, and maintenance of tissue 
homeostasis (Faulk et al. 2014). In turn, dysfunction of ECM dynamics leads to 
unregulated cell proliferation and differentiation causing severe pathological 
events such as fibrosis and cancer (Rozario and DeSimone 2010; Lu et al. 2011). 
The secretion of the ECM starts already at the embryonic stage and its remodeling 
is an important mechanism by which tissue formation is regulated (Rozario and 
DeSimone 2010; Lu et al. 2011). The ECM is modified and degraded by enzymes 
secreted by the cells. The most important enzymes in ECM remodeling are matrix 
metalloproteinases (Lu et al. 2011). 
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ECM proteins are functionally diverse; both rigid, elastic, wet, and sticky 
proteins are needed in the tissue formation and maintenance (Mecham 2001). 
Biochemically, ECM components can be divided into proteins, proteoglycans, and 
glycoproteins (Rozario and DeSimone 2010; Lu et al. 2011). Fibrillar collagens and 
elastin form fibrils and determine the viscoelasticity and tensile strength of the 
tissue. Fibronectin and laminins contribute as building blocks of the matrix network 
and connecting proteins.  ECM occupies only a very limited part of a healthy liver 
and is restricted to portal triads, sinusoids, and central veins (Bedossa and Paradis 
2003). In the plates of hepatocytes, the ECM is located in spaces of Disse (Martinez-
Hernandez and Amenta 1995). 
The most abundant ECM proteins the liver are collagens which also are the most 
frequently found proteins in a human body compromising approximately 30% of 
the total protein mass (Bedossa and Paradis 2003; Ricard-Blum 2011). Out of the 
described 28 members of the collagen family, fibrillar collagen, types I, III, and 
V, and basement membrane collagen, types IV and VI, have been described in the 
liver (Y. Wang et al. 2011; Martinez-Hernandez and Amenta 1995). In addition to 
collagens, other matrix components found in the liver are glycoproteins, including 
laminins, fibronectin, and tenascin, and proteoglycans, such as hyaluronic acid, also 
called as hyaluronan, heparan, and chondroitin sulfate (Bedossa and Paradis 2003). 
Even though several groups have examined the liver ECM proteins, more studies are 
still needed to understand their relative quantities in different locations.
Laminins (LNs) are present predominantly in the basement membrane in most 
tissues in human and they bind to cell surface via integrin and nonintegrin receptors 
(Durbeej 2010; Malinda and Kleinman 1996). These multidomain heterotrimers are 
named on the basis of their α, β, and γ chains (Aumailley et al. 2005) and different 
subtypes can serve distinct biological functions (Colognato and Yurchenco 2000). 
By now, 18 laminin isoforms have been described in the literature (Durbeej 2010). 
Out of these, at least LN-211/221, LN-411/421, and LN-511/521 are found in adult 
human liver (Kikkawa et al. 2008; Liétard et al. 1998). According to Kikkawa and 
co-workers, LN-511 and LN-521 are the main laminin isoforms in the liver (2008). 
Presence of LN-111 in the adult liver is uncertain. Expression of laminin α1 chain 
mRNA in human liver has been reported (Liétard et al. 1998) but in other studies 
the α1 chain protein was not found (Virtanen et al. 2000; Kikkawa et al. 2008). 
In general, distribution of laminin isoforms in the human liver has not yet been 
broadly studied and thus a complete picture on their localization can not be made.
Fibronectin is a multidomain protein that binds to cell surface receptors, 
collagens, and other fibronectin molecules (Schwarzbauer and DeSimone 2011). 
Fibronectin is expressed in most human tissues (Stenman 1978), and it is abundant 
in liver as well (Martinez-Hernandez and Amenta 1995). Proteoglycans are a 
heterogenous group of macomolecules composing of glycosaminoglycans (GAGs), 
linear polysaccharides, bound to a core protein. Proteoglycans are categorized 
based on their GAG chain and size. Degree of sulfation of GAGs and proteoglycans is 
believed to play an important role in intahepatic differentiation processes (Y. Wang 
et al. 2010).  
The ECM chemistry changes during the development, and in the adult liver 
expression of the matrix proteins vary between the zones. (McClelland et al. 2008; 
Y. Wang et al. 2010). In periportal areas, zone 1, the matrix is composed of laminins, 
collagen types I, III, IV, and V, fibronectin, hyalyronan, entactin, perlecan, and 
20
chondroitin sulfate proteoglycans as shown in animal and human studies (Kikkawa 
et al. 2008; Seebacher et al. 1997; McClelland et al. 2008;  Turner et al. 2011; Y. Wang 
et al. 2010; Mazza et al. 2015; Roskams et al. 1995). Kikkawa and co-workers (2008) 
reported that LN-511 is abundant in the bile duct where fibronectin expression has 
been reported to be low or absent (Hahn et al. 1980). Fibronectin, in turn, is the 
most abundant ECM protein in the space of Disse (Martinez-Hernandez and Amenta 
1995). Other ECM components localized in spaces of Disse include all types of 
collagen found in the liver and perlecan (Martinez-Hernandez and Amenta 1995; 
Y. Wang et al. 2011; Mazza et al. 2015). Laminin is not present in the sinusoids of a 
healthy liver (Martinez-Hernandez and Amenta 1995; Kikkawa et al. 2008). Elastin 
is expressed in the whole liver lobule (Y. Wang et al. 2010; Turner et al. 2011; Van 
Eyken et al. 1990)
The matrix close to the central vein, zone 3, contains collagens type I, IV, and VI 
and a weak expression of collagen type III, fibronectin, syndecans, and highly sulfated 
heparan proteoglycans (McClelland et al. 2008; Y. Wang et al. 2011; Mazza et al. 
2015). Zone 3 matrix differs from typical epithelial basement membrane by almost 
total absence of laminins and entactin, but contains large amounts of tenascin (Van 
Eyken et al. 1990; Y. Wang et al. 2010; Turner et al. 2011). Low or absent expression 
of laminin isoforms in zone 3 was confirmed by Kikkawa et al. (2008). 
The matrix chemistry within intrahepatic stem cell niche is only partially 
characterized (Furth et al. 2013). The suggested ECM components include hyalyronan, 
collagen type III, α6β4 integrin-binding form of laminin, and chondroitin sulfate 
proteoglycan with minimal sulfation (Furth et al. 2013; Seebacher et al. 1997; L. Zhang 
et al. 2008; Y. Wang et al. 2010; Turner et al. 2011). As stem cells migrate from the 
niche, the surrounding GAGs and more extensively sulfated proteoglycans together 
with growth factors direct the differentiation process (Y. Wang et al. 2010). The 
microenvironment of hepatoblasts already differs from the stem cell niche consisting 
collagen types III, IV and V, α3β1 integrin-binding form of laminin, normally sulfated 
chondroitin sulfate proteoglycan, and heparan sulfate proteoglycans as proposed by 
Y. Wang and co-workers (2010).
2.2. Liver cells sources for in vitro culture
Human liver cell cultures have multiple applications both as in vitro test systems and 
in tissue engineering. Of the liver cells, hepatocytes are needed in drug development 
for metabolic profiling of drug candidates (FDA 2012). Primary hepatocytes serve as 
the gold standard for in vitro drug biotransformation and liver toxicity testing even 
though their limitations in terms of availability, rapid loss of metabolizing capacity, 
and batch-to-batch variation are well recognized (LeCluyse and Alexandre 2010). 
Contradictory to liver tissue, the isolated primary hepatocytes have low proliferation 
capacity in vitro which hampers their use (Fausto and Campbell 2003; Ramboer et 
al. 2014). After recognizing that hepatic functions of primary hepatocytes decrease 
rapidly during culture (Bissell 1973) numerous culture improvements by using 
various matrices, devices, and flow-based systems have been described (Bissell et al. 
1987; Michalopoulos and Pitot 1975; Uygun et al. 2010; Sellaro et al. 2010; C. Lin et 
al. 2015). 
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Hepatocyte cell lines can be obtained from tumors or by oncogenic immortalization 
and thus have an unlimited lifespan (Guillouzo and Guguen-Guillouzo 2008; 
Rodríguez-Antona et al. 2002). Compared to primary hepatocytes, hepatic cell lines 
exhibit a more stable phenotype, are easily available, and they can be genetically 
manipulated (Gomez-Lechon et al. 2010). However, their major limitation is 
their relatively weak metabolizing capacity. Only a few hepatic cell lines express 
some liver-specific functions (Gomez-Lechon et al. 2010; Guillouzo and Guguen-
Guillouzo 2008). 
In addition to primary isolations and immortalized cell lines, hepatocyte-like cells 
can be obtained from PSCs. In 1998 Thomson and co-workers established the first 
hESC lines. Cells derived from the inner cell mass of a blastocyst maintained capacity 
to self-renew and their pluripotency, capability to form all three germ layers, when 
expanded in vitro (Thomson et al. 1998). Only less than ten years later, a method 
for reprogramming pluripotent stem cells from somatic cells was described (K. 
Takahashi and Yamanaka 2006; Yu et al. 2007; K. Takahashi et al. 2007). These 
cells, named as induced pluripotent stem cells, were produced by delivering key 
transcription factors related to pluripotency via viral transduction into the cells 
in vitro. Thereafter, hiPSCs have been reprogrammed from various somatic cell 
types and by several alternative methods such as non-integrating vectors, small 
molecules, and microRNA (Okita et al. 2008; Shi et al. 2008; Anokye-Danso et al. 
2011). Generally, hiPSCs exhibit similar properties to those of hESCs but do not 
share the same ethical concerns. As the hPSCs have an ability to form all cell types 
of an adult body they are highly interesting sources of cells for various human cell-
based applications including disease modelling, drug screening, and cell therapies. 
Hepatic differentiation of the hPSCs has already been broadly studied (Cai et al. 
2007; Duan et al. 2010; Hay et al. 2008; Si-Tayeb et al. 2010b). Still, obtaining fully 
mature, in vivo counterparts mimicking hepatocytes from hPSCs is challenging and 
none of the current protocols entirely fulfil this task. Alternative stem cell sources 
for hepatic differentiation are hepatic stem cells and mesenchymal stem cells (MSC) 
(X. Zhang and Dong 2015; Y. Wang et al. 2011). In addition, direct reprogramming 
of fibroblasts to hepatocytes has been recently described (Huang et al. 2014).
2.3 Matrix-guided liver cell cultures
It has been stated that hepatocytes lose their phenotypic functions once isolated 
from liver because the cell-matrix interactions are disrupted (Kikkawa et al. 2011). 
Liver environment can be simulated in vitro by using several approaches. Liver 
tissue can be decellularized and used as a native scaffold for reseeding cells in vitro. 
ECM proteins, individually or in combinations, provide cues from the liver matrix 
to cultured cells. Alternatively, the liver microenvironment can be mimicked with 
biologically inactive biomaterials to resemble mechanical properties of the liver. 
This chapter describes how different matrices, both 2D and 3D systems, have been 
used to culture human liver cells, including primary isolations and liver cell lines, or 
facilitate the hepatic differentiation of stem cells in vitro. The materials discussed 
are categorized into three groups: liver tissue-derived matrices, liver ECM-based 
matrices, and artificial liver mimicking matrices. Due to the high number of 
published matrices this review can only give examples from each matrix category. 
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The non-matrix-based culturing techniques, such as suspension cultures or culture 
models built only on co-culture setup or flow systems, are not included in this review. 
Figure 3 gives an overview of the used matrix-guided liver cell culture approaches.
Figure 3 Different approaches to mimic liver tissue in a dish. Liver-derived 
acellular matrices (ACM) have native liver structure and matrix chemistry. Cell sheet–
derived ACMs can be made from cell lines. Two-dimensional (2D) culture can be performed 
on liver extracellular proteins (ECM) or synthetic polymers. Liver structure or stiffness can 
be resembled with scaffolds made from natural or synthetic biomaterials. Hepatic cells can 
be embedded in hydrogels, which mimic liver stiffness or matrix chemistry, to form three-
dimensional (3D) spheroids. Picture is inspired by Chan and Leong 2008.
2.3.1 Liver-derived biomaterials
Native liver tissue can be used for in vitro cell culturing after decellularization, a 
process which aims to remove all cellular materials from the tissue. The obtained 
acellular matrices (ACM) can be used as such or they can be further processed into 
powders and gels (Uygun et al. 2010; Y. Wang et al. 2011; Sellaro et al. 2010). After 
first being described in 1948, techniques for decellularization and reseeding the 
cells have greatly improved and currently ACMs are promising culture materials for 
many biomedical applications (Hinderer et al. 2016).
2.3.1.1. Whole liver acellular matrices 
Decellularized whole organs are the most natural, in vivo simulating scaffolds 
since tissue macroarchitecture and matrix microarchitecture can be maintained 
after the decellularization process (Hoshiba et al. 2010). The structure, chemical 
composition and functions of a matrix are tissue specific but not species specific 
(Y. Wang et al. 2011). Though, differences in ECM component quantities between 
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species have been reported (Dahms et al. 1998). Animal-derived liver ACMs can be 
used for culturing human cells because ECM proteins are well-conserved among 
species and xenogeneic matrices are tolerated (Hoshiba et al. 2010). 
Both whole liver and liver slices have been used to create liver structure 
mimicking cell culture scaffolds. The aim in tissue decellularization is to remove a 
whole cell population and to restore the complete tissue matrix without affecting its 
3D structure, surface topology, and biological activity (Faulk et al. 2014). However, it 
is accepted that removal of cells from their integrin-bound anchors and intercellular 
adhesion sites while maintaining surface topography and resident ligands of the 
ECM intact is demanding (Badylak et al. 2012).
The decellularization can be performed by using enzymatic, physical, chemical 
and ionic methods (Badylak et al. 2012). In case of whole liver, the decellularization 
is preferably done by perfusion via the organ’s vasculature, recent innovation that 
preserves the 3D structure of an organ entirely (He and Callanan 2013). The liver 
ACM slices have been prepared by decellularizing liver tissue sheets or sectioning 
the decellularized whole liver (P. Lin et al. 2004; Y. Wang et al. 2011). Before 
reseeding the cells into acellular liver the matrix has to be sterilized which might 
have a harmful effect on the mechanical properties of the scaffold (Badylak et al. 
2015). The sterilization techniques include gamma irradiation, electron beam 
irradiation, and treatment with acid or ethylene oxide (Badylak et al. 2015; Badylak 
2002; Uygun et al. 2010).
The recently described decellularization by perfusion is an attractive method 
to produce bioarticifial liver scaffolds. Wang et al. (2011) reported a four-step 
perfusion decellularization which maintains the collagen content high and the 
remaining growth factors and cytokines were at physiological level. Uygun and 
co-workers (2010) demonstrated the decullarization of rat and bovine livers by 
portal vein perfusion with increasing concentrations of sodium dodecyl sulfate 
(SDS) and sterilized with peracetatic acid. After decellularization, collagen types 
I and IV, fibronectin and laminins, were maintained. The acellular liver scaffold 
was then reseeded with rat primary hepatocytes, which showed similar ALB protein 
expression compared to normal liver. However, ALB and urea production were 
at the similar level as in the cells cultured in between collagen layers, called as 
sandwich culture, a much simpler technique compared to liver ACM. The concept of 
culturing primary hepatocytes in whole liver ACM has also been proven with mouse 
hepatocytes in rat liver ACM (Soto-Gutierrez et al. 2011). 
Wang et al. (2011) used slices made from rat liver ACM for differentiating human 
hepatic stem cells to mature liver cells. Decellularization was performed with four-
step protocol by portal vein perfusion including delipidation, washing step with 
high salt concentration to maintain the insoluble collagens, eliminating nucleic 
acids with nucleases, and finally washing the matrix with cell culture medium to 
remove salts and detergents and to equilibrate the ECM components. After freezing, 
the tissue matrix was sectioned, sterilized and placed to cell culture plates. Gene 
and protein expression data and functionality studies showed that hepatic stem 
cells were able to differentiate to adult liver cell types and liver specific functions 
were higher compared to the cells cultured on collagen type I matrix. Rat and 
human primary hepatocytes have also been cultured on liver ACM slices prepared 
from porcine tissue sheets (P. Lin et al. 2004; Lang et al. 2011). Recently, Mazza 
et al. (2015) described the first decellularization of a human liver. By repopulating 
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cubes cut from the liver ACM with three liver cell types they showed that the ACM 
supported homing of the different cell types into their natural locations. Liver-like 
functions of the recellularized ACM were not examined. 
The acellular scaffolds are promising for regenerative medicine, especially 
for end-stage organ failures (Badylak et al. 2012). So far, transplantation of 
recellularized liver ACM has been tested only in animal studies (Uygun et al. 2010; 
Barakat et al. 2012; Mazza et al. 2015). To scale up the whole liver ACM approach, 
to achieve human-sized organ, researchers have engineered scaffolds from porcine 
and human livers (Baptista et al. 2011; Barakat et al. 2012; Mazza et al. 2015). In 
vitro models based on liver ACM cultures could provide a deep understanding of the 
biotransformation routes and mechanisms of a drug candidate. However, they will 
not be applicable for high-throughput drug testing, at least in the near future, due to 
demanding decellularization and repopulation processes using perfusion systems. 
2.3.1.2 Modified liver acellular matrices
 
Liver ACMs can be further processed to create culture systems with less batch-
to-batch variation compared to native whole tissue ACM. Already in 1980, fibrils 
obtained from homogenized and decellularized rat liver was used for long-term 
culturing of rat hepatocytes (Rojkind 1980). After that, liver ACMs have been used 
to create liver ECM mimicking gels and powders both for 2D and 3D cell culturing 
(J. S. Lee et al. 2014; Sellaro et al. 2010; Y. Wang et al. 2011).
Sellaro et al. (2010) prepared liver ACM gel from porcine liver to culture human 
primary hepatocytes. The hepatocytes were cultured in a sandwich configuration in 
between liver ACM gel layers. ALB secretion remained stable for 10 days in the cells 
cultured in a liver ACM gel system. However, the liver-like functions of the cells 
cultured in ACM gel were not improved compared to Matrigel (described in chapter 
2.3.2.2) sandwich culture. Wang et al. (2011) reported exceptionally long functional 
stability of human primary hepatocytes cultured on pulverized bovine liver ACM. 
Decellularized liver matrix was milled with the presence of liquid nitrogen, mixed 
with culture medium and dispersed to culture wells. The human hepatocytes on 
ACM powder were functional for eight weeks while the cells cultured on collagen 
type I started to die after three weeks. A 3D hydrogel derived from rat liver ACM 
has been used to culture rat primary hepatocytes (J. S. Lee et al. 2014). Lyophilized 
ACM containing collage type I, laminins, and fibronectin was cross-linked by mixing 
with PBS and incubated in neutral conditions at 37°C and used to encapsulate the 
cells. The hepatocytes were viable for a longer period of time in 3D ACM-hydrogel 
culture compared to 3D collagen type I hydrogel. The cells secreted ALB and urea 
over one week but other hepatic functions in vitro were not characterized. 
Liver ACM-derived gel has also been shown to support hepatic differentiation 
of mouse adipose-derived MSCs (X. Zhang and Dong 2015). The cells were plated 
on an ACM gel made from pulverized rat liver ACM and cultured with and without 
the presence of hepatic differentiation inducing reagents. Compared to other tested 
coating agents, collagen, fibronectin and Matrigel, the liver ACM gel supported the 
hepatic differentiation best. The cells treated with inducing agents showed higher 
hepatic functions than the non-treated cells as shown by the secretion of ALB and 
urea. However, the culture of stem cells without soluble factors showed that the 
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culture matrix alone supported induction of the MSCs towards hepatic lineage. 
Compared to the whole liver ACM, the advantage of the modified liver ACM 
culture systems is their flexibility and possibility to decrease batch-to-batch 
variation by pooling several tissues together. However, the 3D structure of native 
liver tissue cannot be resembled with processed ACM culture systems. Nonetheless, 
the cells embedded in suspended or gelified ACMs can be easily transplanted in vivo 
with minimally invasive techniques offering a promising tool for tissue engineering 
(Badylak et al. 2015). 
2.3.2 Liver ECM component-based matrices
The chemistry of liver tissue can be mimicked by using ECM proteins in culture 
systems. The ECM proteins have been used as culture substrata for liver cells since 
the 1970s when hepatocytes were cultured on collagen membranes (Michalopoulos 
and Pitot 1975). Thereafter, ECM proteins, mixtures or individual components, 
have been used as 2D matrices and materials for creating 3D culture systems. The 
ECM component-based matrices are introduced in the three following chapters: cell 
sheet-derived acellular matrices, ECM protein mixtures, and defined ECM proteins.
2.3.2.1 Cell sheet-derived acellular matrices 
Compared to whole organ ACMs, decellularized cultured cells offer a simpler approach 
to mimic liver environment. Cultured cells do not require ethical permission and 
their decellularization can be performed without sophisticated devices. In addition, 
the production of cell line-derived ACMs is more straightforward compared to 
whole organs as the sterilization step can be avoided when performing the cultures 
in the same cell culture facility. The choice of the cell line for ACM construction is 
based on the desired ECM protein or combination of proteins secreted by the cells. 
The cell sheet ACMs have been developed from liver cells but also from other tissue 
types and tumors (Herrema et al. 2006; Vuoristo et al. 2013). The decellularization 
of cultured cells has been performed with distilled water or alkaline solution with 
or without detergent (Herrema et al. 2006; H. Takashi 2007; Vuoristo et al. 2013). 
The ACM can be characterized at the protein level with immunofluorescence, or at 
the structural level with transmission electron microscope. However, the structural 
studies of the cell sheet ACMs are seldom performed. 
Takahashi H. et al. (2007) prepared ACM from immortalized alveolar type II 
epithelial SV40-T2 cells cultured on collagen type I and Matrigel. Mouse primary 
hepatocytes attached to the ACM similarly as to Matrigel but secreted more ALB on 
the ACM than on Matrigel. The authors claimed that the SV40-T2-ACM is superior 
to Matrigel because the matrix contains LN-511/521. Alveolar type II epithelial 
cells are known to secrete laminin a5 chain (Pierce et al. 1998) but its expression 
in the SV40-T2-ACM remains unclear as its characterization was not published by 
Takahashi’s group (H. Takahashi et al. 2007). Another group used HEK293 cells 
overexpressing LN-511 in a similar kind of culture system as Takahashi et al. to 
differentiate mouse ES cells to hepatocytes (Shiraki et al. 2011). Human ES cells 
seeded on LN-511-ACM increased their ALB secretion during the culture period 
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confirming their hepatic differentiation. However, the expression level of ALB 
mRNA was much lower than that in adult liver. The derived hepatic cells were 
metabolically active as shown by induction of CYP3A4 enzyme activity. LN-111 and 
LN-521 expressing human choriocarcinoma cell line-derived ACM has been shown 
to support hepatic differentiation of hESCs and hiPSCs (Vuoristo et al. 2013). The 
hPSCs were plated on top of ACM derived from JAR cells cultured on gelatin and 
differentiated towards hepatic cells with stepwise growth factor treatment. The 
derived cells expressed human ALB in gene and protein level similarly to the cells 
cultured on Matrigel. 
Cell sheet-derived ACMs are relatively fast, easy, and cost-efficient matrices to 
produce. The transfected cell lines offer possibility to create culture matrices with 
specific ECM protein composition mimicking a certain developmental phase or a 
region in the liver. However, the cell sheet-derived ACMs fail to mimic the native 
liver structure which can be restored in whole liver ACMs. 
2.3.2.2 ECM protein mixtures 
Matrigel, protein extract from Engelbreth–Holm–Swarm (EHS) mouse sarcoma 
cells, is the most widely used ECM protein mixture for culturing different cell 
types in vitro (Kleinman and Martin 2005). The EHS cells secrete ECM proteins 
abundantly and commercial Matrigel mainly contains laminin-111 (c. 60%), collagen 
type IV (c. 30%), and entactin (c. 8%) together with numerous other proteins and 
several growth factors (BD Biosciences 2011; Hughes et al. 2010; Streuli et al. 1995). 
Matrigel can be applied in 3D culturing to embed the cells inside the hydrogel or in 
2D cell culturing as a thin coating substrate. 
At the end of the 1980s Bissel and co-workers discovered that Matrigel supports 
the maintenance of primary hepatocytes for a longer period of time than collagen 
type I as shown by ALB secretion of the cells (Bissell et al. 1987). Thereafter, 
numerous cell cultures have been performed on Matrigel coating. In addition to its 
use as a coating substratum, Matrigel can be applied on top of the cell monolayer 
to maintain or improve the morphology, polarity and maturation of the hepatocytes 
(Gross-Steinmeyer et al. 2005; Page et al. 2007; Bachour-El Azzi et al. 2015). 
Page et al. (2007) showed that Matrigel overlay increased the expression of ALB, 
transferrin, and transthyretin in human hepatocytes from four donors compared 
to cells in a control culture system without an overlay. Matrigel overlay had an 
inducing effect on drug metabolizing enzyme expression, especially CYP2B6 and 
glutathione transferases, in human primary hepatocytes (Gross-Steinmeyer et al. 
2005). Compared to the conventional culture system, primary human hepatocytes 
formed more elongated bile canalicular network when overlaid with Matrigel as 
shown by phase contrast microscopy and fluorescence staining of filamentous actin 
(Bachour-El Azzi et al. 2015). In addition, the activity of influx transporter Na+-
dependent taurocholate co-transporting polypeptide was significantly higher in the 
cells in Matrigel overlay culture compared to conventional culture. 
In addition to primary hepatocytes, Matrigel has been commonly applied 
for culturing liver cell lines and stem cells for hepatic differentiation (Ordovás 
et al. 2013; Ramaiahgari et al. 2014; Molina-Jimenez et al. 2012; Hay et al. 
2008). Liver Huh-7 cell line formed functional 3D spheroids when embedded in 
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Matrigel (Molina-Jimenez et al. 2012). Transporter protein MRP2 was localized 
at the apical membrane of the 3D Huh-7 spheroids and the spheroids secreted 
5-chloromethylfluorescein di-acetate (CMFDA) into bile duct-like constructs. 
Ramaiahgari et al. (2014) showed that Matrigel culture also supports long-term 
3D culture of human hepatocarcinoma HepG2 cells. During one month in culture, 
HepG2 spheroids showed upregulation in ALB secretion, formation of bile duct-
like structures and functional biliary transport. The gene expression of metabolic 
enzymes was higher in 3D cultured cells than in 2D culture. In addition, the enzyme 
activities of CYP2C9, CYP3A4, and CYP2D6 were increased in 3D compared to 2D. 
The maintenance of hPSCs is commonly done on Matrigel coating. Thus, many 
researchers have described hepatic differentiation of hPSCs on Matrigel (Hay et al. 
2008; Si-Tayeb et al. 2010b; Hannan et al. 2013). Indeed, hepatic differentiation 
on Matrigel can be regarded as a standard culture condition to which many new 
culture systems are being compared. In conclusion, Matrigel provides both ECM 
proteins and growth factors (growth factor reduced product also on the market) 
to cell culture models. However, one of the drawbacks of Matrigel is undefined 
components in the product leading to possible variations between independent cell 
culture experiments (De Bartolo and Bader 2013). 
Another described ECM protein mixture applied in liver cell culturing, Adipogel, 
is extracted from conditioned media of cultured 3T3-L1 murine preadipocytes 
(Sharma et al. 2010; Sharma et al. 2011). Adipogel contains ECM proteins collagen 
type IV, laminins, HA, and fibronectin and numerous growth factors such as 
hepatocyte growth factor and vascular endothelial growth factor (Sharma et al. 
2010). Sharma et al. (2011) showed that rat hepatocytes overlaid with Adipogel 
secreted over two-times more ALB compared to cells in collagen sandwich culture. 
However, the urea production of the cells was at a similar level. 
Similarly to Matrigel, the composition of Adipogel has not been completely 
characterized but it offers a new, cost-effective ECM matrix for in vitro hepatocyte 
cultures (Sharma et al. 2010). One major drawback of both Matrigel and Adipogel is 
their origin and thus the cells cultured on these animal-derived matrices cannot be 
taken into clinical applications.  
2.3.2.3 Defined ECM proteins
Individual ECM proteins can be extracted from animals or human or produced 
either in eukaryotic and prokaryotic expression systems or in transgenic organisms 
(Ruggiero and Koch 2008). Using one ECM protein at a time makes it possible 
to study the specific effect of the protein to cell functionality. In addition, ECM 
proteins are usually cost-effective culture formats and their use does not require 
sophisticated laboratory devices. This chapter introduces how collagens, laminins, 
fibronectin, vitronectin, and hyalyronic acid have been applied in liver cell cultures. 
In the 1970s, Michalopoulos and Pitot successfully applied collagen membranes 
in culturing primary hepatocytes (Michalopoulos and Pitot 1975). Thereafter, 
numerous collagen-based matrices have been described. The adhesion of hepatocytes 
to several types of collagen has been proven but collagen type I is most used for cell 
culturing (Rubin et al. 1981). McCelland et al. (2008) showed that collagen types III 
and IV, expressed in the zone 1 of the liver lobule, facilitated cell proliferation, while 
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collagen type I, a zone 3 matrix protein, elicited commitment to hepatic progenitors. 
It was soon noticed that monolayer culture of primary hepatocytes on a single 
collagen type I layer does not support long-term viability or cell functionality (Bissell 
et al. 1987). Dunn et al. (1989) showed that double collagen layer, below and above 
the cultured cells, prolongs the time of ALB secretion of rat hepatocytes. Currently, 
collagen type I sandwich culture is one of the standard culture systems for primary 
hepatocytes (LeCluyse et al. 2004). Collagen type I has been applied in hepatic 
stem cell differentiation as 2D coating substratum or as 3D hydrogel (X. Zhang 
and Dong 2015; Baharvand et al. 2006). Baharvand et al. (2006) examined hepatic 
differentiation of hESCs in 2D and 3D matrices made from collagen type I. They 
noticed that secretion of AFP and urea in 3D cultured cells was higher than those in 
2D culture. However, the ALB secretion in 2D and 3D cultures were at a similar level. 
Commercial 3D collagen type I matrix, RAFT™ 3D Cell Culture System, was shown 
to promote maturation of hiPSC-derived pre-differentiated hepatic cells (Gieseck et 
al. 2014). Interestingly, the maturation was evident only if the pre-seeded hepatic 
cells were seeded to 3D matrix in aggregates. When seeded to 3D collagen as single 
cells the ALB secretion was dropped, indicating the importance of cell-cell contact 
for mature hepatocytes.  
Recently laminins have been actively studied for culturing hepatic cells. The 
use of cell sheet-derived ACMs containing laminins have been described above. 
Recombinant laminins LN-111 and LN-521 have been successfully used for 
culturing hepatic cells (Cameron et al. 2015; Takayama et al. 2013; Takayama et 
al. 2014). Human ES cells, plated on LN-521 or a mixture of LN-521 and LN-111, 
were differentiated to functional hepatocyte-like cells (Cameron et al. 2015). The 
derived cells on LN matrices showed higher CYP1A2 and CYP3A enzyme activity 
compared to cells cultured on Matrigel. The CYP3A enzyme activity in cells on 
LN-521 and LN-111 were highest from day 20 to day 24 after which the activity 
dramatically decreased. Cameron et al. also showed that the derived hepatocyte-like 
cells had functional efflux transport as evidenced by a vectorial transport assay with 
5(6)-carboxy-2′,7′-dichlorofluorescein diacetate (CDFDA). Takayama et al. (2013) 
tested four different laminins for culturing hESC and hiPSC-derived hepatoblasts. 
The attachment of pre-differentiated hepatoblasts to LN-111 was approximately 
three-times higher than that to LN-211, LN-411, and LN-511. The group showed that 
they were able to maintain the hepatoblasts cultured on LN-111 up to 15 passages as 
shown by stable AFP protein expression in the entire cell population. In addition, 
10-times passaged hepatoblasts differentiated better to hepatocytes compared to 
hepatoblasts without passaging as shown by higher expression of CYP enzymes, 
and higher ALB and urea secretion. Later, the same group differentiated human 
liver-derived iPSCs to hepatocyte-like cells in a similar culture setting with some 
modifications (Takayama et al. 2014). Again, the cells passaged at the hepatoblast 
stage showed higher expression of typical hepatocyte markers and secreted more 
ALB and urea compared to the cells without passaging. Kikkawa et al. (2011) showed 
that peptides derived from laminin chains are also able to support the attachment 
of rat hepatocytes. Even though the gene expression of hepatic markers were not 
improved compared to Matrigel, the synthetic peptides offer a defined and xeno-
free culture matrix. 
As fibronectin is expressed in most human tissues, it has been widely used as a 
coating material for culturing different cell types (Stenman 1978). Indeed, it was 
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stated over 30 years ago that fibronectin is a relatively nonspecific cell attachment 
protein (Carlsson et al. 1981; Donato et al. 1995). In liver, fibronectin is expressed 
in the whole lobule but most abundantly in zone 3 (Y. Wang et al. 2011). Several 
studies have shown that fibronectin supports the attachment and viability of 
hepatocytes (Carlsson et al. 1981). However, it has been revealed that fibronectin 
did not promote the attachment of hepatic progenitors, isolated from human fetal 
liver, but instead caused rapid cell death (McClelland et al. 2008). 
Cell adhesion glycoprotein vitronectin has been shown to support the hepatic 
differentiation of hPSCs (Nagaoka et al. 2015).  Nagaoka et al. combined a 
fragment of vitronectin containing RGD (arginine-glycine-asparagine) peptide into 
immunoglobulin G antibody and plated hPSCs on this matrix, called as R-Fc. The 
derived hepatic cells were positive for HNF4A as shown by immunofluorescence 
and had a capacity for activity uptake of indocyanide green, a specific function of 
hepatic cells. However, the expression of AFP revealed that the cells were not fully 
mature. The R-Fc matrix could offer an alternative, highly defined coating substrate 
to Matrigel. However, based on the gene expression profile Matrigel-cultured cells 
expressed more mature hepatocyte markers compared to R-Fc-cultured cells.  
Hyaluronic acid is a nonsulfated glycosaminoglycan abundantly expressed in 
stem cell niches and thus it is an attractive culture matrix for hepatic stem cells 
(Turner et al. 2013). HA hydrogel has been shown to maintain the phenotype of 
hepatic stem cells and moreover, support the hepatic differentiation of this cell type 
(Lozoya et al. 2011; Turner et al. 2013). Lozoya et al. (2011) showed that hepatic 
stem cells isolated from fetal human liver can be differentiated towards hepatic 
progenitors and hepatocytes when cultured in 3D HA hydrogel. They noticed that 
stiffness of the hydrogel plays an important role in the hepatic differentiation. The 
hydrogel with shear modulus, a measure of gel stiffness, of 73-220 Pa guided the 
hepatic differentiation the best. 
In summary, the defined ECM proteins are easy to use and their commercial 
availability is high. Some of the commercial ECM proteins are xeno-free and GMP-
grade which enable the transfer of cultured cells to clinical use. However, the single 
ECM protein-based cell culture matrices do not mimic the complexity of matrix 
chemistry found in liver.
2.3.3 Artificial liver mimicking matrices
Numerous biomaterials that do not originate from liver tissue or do not contain 
any liver matrix components have been applied in liver cell culturing either as 
2D matrices or 3D hydrogels and scaffolds. The biomaterials described below are 
categorized as naturally-derived and synthetically-derived biomaterials depending 
on their source of polymer. The combinations of two natural biomaterials or a natural 
and a synthetic biomaterial, so called hybrid biomaterials, are introduced as well. 
Liver ACMs and ECM component-based matrices also belong to the classification of 
natural biomaterials but are already introduced in chapters 2.3.1 and 2.3.2. 
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2.3.3.1 Natural biomaterials
The source of natural biomaterials ranges from plants to mammals and the naturally-
derived polymers include proteins such as silk, fibrin, and gelatin, or polysaccharides, 
for example, alginate, chitosan, and cellulose (Allen et al. 2015; Bhattacharya et al. 
2012). As any other cell culture matrices, naturally-derived biomaterials can be used 
to create both 2D and 3D culture systems. This chapter gives examples of the use of 
alginate, chitosan, silk, and cellulose in liver cell cultures. Other described natural 
biomaterials for liver cell culturing include materials such as fibrin and gelatin 
(Chinzei et al. 2002; X. Wang et al. 2006; Bruns et al. 2005).
Alginates are linear polysaccharides commonly obtained from brown seaweed 
(Lee and Mooney 2001). These biodegradable polymers are one of the most used 
biomaterials in tissue engineering (N. Lin et al. 2010; Rowley et al. 1999). Alginate 
scaffolds have been shown to support culture of various types of liver cells. However, 
2D alginate films seem to inhibit the attachment of hepatocytes which is most likely 
caused by the lack of interaction between the material and cells (Glicklis et al. 2000). 
Adult rat hepatocytes showed stable ALB secretion in 3D alginate scaffold for seven 
days while rat newborn liver cells continued producing ALB for over 40 days (Dvir-
Ginzberg et al. 2003; Dvir-Ginzberg et al. 2008). Indeed, 3D alginate scaffold, 
cross-linked with D-gluconic acid by freeze-drying, supported the maturation 
of cells isolated from newborn rat liver cells and the formed spheroids secreted 
approximately 3000-times more ALB than the cells cultured in a similar scaffold 
fabricated from collagen (Dvir-Ginzberg et al. 2008). Lin et al. (2010) proved that 
3D alginate scaffold is also suitable for hepatic differentiation. They differentiated 
rat MSCs into hepatocyte-like cells in calcium cross-linked alginate scaffold. The 
hepatic differentiation was confirmed by increased ALB and urea production over 
the culture period. However, the differentiation was not performed in standard 2D 
culture so it remains unclear if the 3D configuration in alginate scaffold improved 
the hepatic maturation. 
Chitosan is derived from chitin containing shells such as crabs and shrimps after 
purification and enzymatic or chemical conversion steps from chitin to chitosan 
(Cheung et al. 2015). Li et al. (2003) compared hepatic functions of rat primary 
hepatocytes plated on a chitosan monolayer and in a 3D porous chitosan scaffold. 
After one week of culture, ALB secretion in 3D cultured cells was approximately 
two-times higher than in 2D cultured cells, while there was no difference in urea 
production. In addition to primary hepatocytes, chitosan matrices have been used to 
culture HepG2 cells (Verma et al. 2007) and to differentiate human MSCs towards 
hepatocyte-like cells (Cheng et al. 2012).
Fibrillar biomaterials such as silk and nanocellulose have been shown to elicit the 
growth of liver cell lines (Kundu et al. 2013; Bhattacharya et al. 2012). Kundu et al. 
(2013) demonstrated HepG2 cell culture in 3D silk scaffold. Silk fibroins, produced 
by silkworms, were fabricated into 3D scaffold by molds and lyophilized. HepG2 
cells were viable in the silk scaffold for 21 days but the group did not characterize the 
hepatic functions of the cells. Wood-derived nanofibrillar cellulose (NFC) is obtained 
from plant cell walls by enzymatic hydrolysis and mechanical shearing (Pääkkö et al. 
2007). NFC hydrogel is formed at low fiber concentrations and has been shown to 
support the culture of HepG2 and HepaRG cells (Bhattacharya et al. 2012). HepaRG 
cells were viable after one month of 3D culture and secreted ALB at increasing trend 
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during the culture therefore demonstrating the maturation towards hepatocytes. 
Cellulose has also been formulated into macroporous scaffolds to culture HepG2/
C3A and primary hepatocytes (Yue at al. 2010; Nugraha et al. 2011).   
2.3.3.2 Synthetic biomaterials 
In principle, synthetic chemistry allows creating cell culture matrices with nearly 
any shape, stiffness, porosity, or charge. Synthetic biomaterials can provide a more 
controlled and reproducible microenvironment for cultured cells compared to the 
naturally-derived biomaterials (Lutolf and Hubbell 2005). Synthetic polymers are 
often functionalized with peptides or growth factors to increase their biochemical 
activity as they do not offer biological cues for cells by themselves. 
Polyurethanes are regarded as one of the most biocompatible materials (Zia et al. 
2015). Hay et al. (2011) screened 380 polyurethane and polyacrylate polymers to 
identify suitable synthetic matrices for 2D culturing of hPSC-derived hepatocyte-
like cells. Polyurethane 134 polymer was found to support the attachment of pre-
differentiated hepatocytes and maintain their liver-specific functions. Compared to 
Matrigel culture, the cells cultured on polyurethane 134 produced more fibrinogen, 
transthyretin, and fibronectin, and their CYP1A2 activity was approximately six-
times higher.
3D scaffolds have been developed from numerous synthetic polymers. Adwan et 
al. (2013) described that highly porous 3D scaffold made from polyhedral oligomeric 
silsesquioxane and poly-ε-caprolactone (PCL) supported hepatic functions of 
HepG2 cells for two weeks as shown by their urea secretion. Lee and co-workers 
(2009) showed that the size of HepG2 spheroids can be precisely controlled in an 
inverted colloidal crystal scaffold made from polyacrylamide. The spheroids with 
diameter of 50 µm showed higher ALB production over the culture period compared 
to larger spheroids. However, ALB secretion was not improved compared to 2D 
cultured cells. Poly-L-lactic acid mixed with polyglycolic acid scaffold was used for 
hepatic differentiation of mouse ESCs (Liu et al. 2010). Embryoid body-derived cells 
were mixed with Matrigel and cell culture medium and seeded onto scaffold. During 
20 days in culture, upregulation of ALB secretion confirmed hepatic maturation of 
the derived cells. Hepatic differentiation of mouse MSCs in electrospun polyamide 
fibers coated with Matrigel was demonstrated by Piryaei et al. (2011). Scaffold made 
from positively charged fibers induced hepatic differentiation more than the scaffold 
with negative charge as shown by ALB and CYP1A1 protein expression. However, 
there was no clear difference in urea, AFP, and ALB production between these two 
scaffolds.
Polyethylene glycol (PEG)-based biomaterials are widely applied in cell cultures 
due to their versatility (Underhill et al. 2007). PEG-biomaterials are biocompatible, 
hydrophilic and easily crosslinked by light (Lutolf and Hubbell 2005; Underhill et 
al. 2007). Rat primary hepatocytes encapsulated in PEG-hydrogel prolonged their 
ALB and urea secretion when the hydrogel was functionalized with adhesive peptide 
RGDS (arginine-glycine-asparagine-serine) (Underhill et al. 2007). Improved 
hepatic functions by additive RGD peptide were also shown by Itle et al. (2005) 
with liver cell line. PEG-diacrylate (PEGDA) hydrogel functionalized with RGD 
significantly improved the ALB secretion in SV-40 transformed murine hepatocytes.
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Commercial peptide hydrogel, Puramatrix™, has been shown to support 3D 
culture of rat hepatocytes and HepG2 cells (S. Wang et al. 2008; Malinen et al. 
2012). Rat hepatocytes in 3D Puramatrix secreted ALB and urea over 20 days 
at the same level compared to the cells cultured in collagen type I sandwich and 
Matrigel but exhibited approximately two-times higher CYP3A4 activity compared 
to collagen sandwich culture on day nine (S. Wang et al. 2008). Malinen et al. (2012) 
showed that HepG2 cells formed 3D spheroids with bile duct-like constructs with 
efflux transporters MDR1 and MRP2 localization. In addition, the functionality 
of hepatobiliary transporters was confirmed by demonstrating the transport of 
fluorescein diacetate into formed canalicular-like structures. Puramatrix can also be 
used in sandwich culture systems as an alternative to ECM proteins (Genové et al. 
2009). Rat hepatocytes cultured in between two layers of Puramatrix secreted ALB 
at a similar level as the cells in standard collagen sandwich after one week culture 
period. However, long-term stability of hepatic functions should be further studied 
to reveal if the synthetic sandwich could replace traditionally used collagen.
2.3.3.3 Hybrid matrices
Hybridization of biomaterials offers more possibilities to modify the matrix 
characters to create a desired culture matrix. By combining a natural and a synthetic 
biomaterial or two or more naturally-derived polymers together the physicochemical 
and biological properties of a matrix can be tuned. These hybrid materials are 
also called bio-artificial or biosynthetic polymeric materials (Zia et al. 2015). Due 
to the fact that possibilities to design different types of hybrid biomaterials are 
nearly unlimited, many hybrid matrices have already been suggested for liver cell 
culturing. Thus, this chapter gives examples of the used matrices rather than a 
complete review. 
Multiple biomaterials that do not originate from liver have been combined with 
ECM proteins, especially with collagen type I, to increase cell-matrix interactions. 
Biologically inert PCL was combined with collagen type I and polyethersulfone to 
achieve porous nanofiber scaffold to differentiate MSCs towards hepatocyte-like 
cells (Kazemnejad et al. 2009). Compared to standard 2D culture, the 3D cultured 
cells secreted approximately two-times more ALB indicating improved status of 
hepatic differentiation. Li et al. (2010) also used 3D scaffold made from polylactic-
co-glycolic acid and collagen type I for hepatic differentiation of MSCs. Similarly, 
they showed that 3D scaffold supported the hepatic differentiation better compared 
to monolayer cultured as shown by ALB and urea synthesis. Collagen type I was also 
combined with PEGDA to fabricate inverted colloidal crystal scaffolds (M. H. Kim et 
al. 2015). By increasing the collagen concentration in the matrix the ALB secretion 
of Huh-7 cells increased. In addition to ECM proteins, polymers can be conjugated 
with galactose to increase cell adhesion (Yin 2003; Stampella et al. 2015). Stampella 
et al. (2015) demonstrated that HepG2/C3A cells secreted significantly more ALB 
and urea when they embedded in alginate scaffold supplemented with galactose as 
compared to a standard monolayer culture on cell culture plastic.
The mechanical properties of natural hydrogels can be improved by combining 
them with synthetic polymers. HA can be coupled with both natural and synthetic 
polymers. Commercially available HyStem® (previously Extracel®), HA hydrogel 
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crosslinked with PEGDA, and HyStem®-C, which contains additional gelatin 
component, are in situ gelifying hybrid hydrogels of which stiffness can be altered by 
changing the ratio of the kit’s components (Shu et al. 2006; Prestwich et al. 2007). 
Rat primary hepatocytes cultured in HyStem maintained their CYP1A2 activity for 
17 days, five days longer than cells cultured in standard 2D format (Prestwich et 
al. 2007). Lozoya et al. (2011) performed an extensive screen of different ratios 
of HA and PEGDA to find the optimal matrix for human hepatic stem cells. They 
noticed that stiffness of the HA matrix controls the differentiation to hepatoblasts 
and committed progenitors in vitro. The secretion of AFP, ALB and urea increased 
in hydrogels with lower concentration of HA suggesting hepatic lineage maturation. 
Also, You et al. (2013) studied the effects of hydrogel stiffness to hepatic cell 
functionality. Primary rat hepatocytes were plated on heparin-PEGDA matrices with 
stiffness range from 10 to 110 kPa. Cell attachment, morphology, ALB expression 
and ALB secretion were significantly higher on soft, 10 kPa, matrices compared to 
stiffer gels. Heparin-PEGDA hybrid matrix was also used to encapsulate rat primary 
hepatocytes to obtain 3D spheroids (M. Kim et al. 2010). The hepatic functions of 
hepatocytes were negligible when the cells were cultured in matrix containing only 
PEGDA while the ALB secretion in heparin-PEGDA was maintained for 20 days in 
culture.
Hybrid biomaterials are also used to build liver structure mimicking culture 
scaffolds. Jiankang et al. (2009) developed a chitosan-gelatin scaffold that resembles 
the architecture of liver lobule for culturing rat hepatocytes. The hepatocytes secreted 
ALB and urea over the studied nine days but further functional studies should be 
performed to estimate whether the suggested matrix could be used, for example, for 
drug testing. 3D printing techniques have opened new possibilities to control the 
organization of cells and matrices in vitro. Billiet et al. (2014) fabricated cell-laden 
3D constructs by printing hydrogel and HepG2 cells. The HepG2 cells were mixed 
with gelatin-methacrylamide hydrogel and dispensed into a symmetrical 3D fiber 
network. Viability of the printed cells was high and ALB and HNF4A expressions 
were maintained after the printing. 3D printing offers attractive technique for 
culturing hepatocytes which are highly organized cells in vivo. However, more 
studies are needed to confirm the potential of this technique.
Finally, the most important criteria for selection of a biomaterial for a cell culture 
system are biocompatibility and non-toxicity. In general, the advantage of natural 
biomaterials is their better biocompatibility compared to synthetic materials. 
However, the composition of natural matrices is often poorly defined which might 
cause variability between individual cell culture experiments. Both naturally-
derived biomaterials and synthetic biomaterials can be produced with various 
techniques, such as electrospinning, photolithography, and 3D printing, and their 
properties can be tuned by altering, for example, cross-linking density or changing 
the functional groups. Hybridization of different types of materials enables even 
more possibilities to create desired culture conditions. A drawback of many artificial 
liver mimicking matrices is that they do not provide biological binding sites for cells 
and thus the cell-material interactions are missing. Instead, some of the matrices 
form ionic interactions with cells, or the scaffold provides only structural support (J. 
Li et al. 2003; Glicklis et al. 2000).
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3 Aims of the study
The hypothesis of the thesis was to show that new biomaterials for in vitro hepatic 
differentiation can be found by mimicking the natural ECM and by studying the 
natural mechanisms. To prove the hypothesis, this thesis focuses on finding, 
characterizing, and testing matrices for maturing human liver progenitor cells 
to functional hepatocytes and differentiating the hPSCs into hepatic lineage. The 
specific aims were: 
1. To construct functional spheroids in natural and hybrid 3D hydrogels and 
to couple the culture format with high-resolution imaging to analyze intact 
spheroids (I, II).
2. To test the hypothesis that a liver progenitor-like matrix can support hepatic 
lineage specification of hPSC-derived DE cells (III, IV). 
3. To study if characterization of ECM proteins secreted by liver progenitor cells 
can lead to identification of hepatic lineage stage specific biomaterials and 
development of defined ECM protein-based matrices (III, IV).  
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4 Materials and methods
The materials and methods used are briefly described in this chapter. The detailed 
descriptions of the experimental procedures and methods are found in the original 
publications I-IV. Table 1 summarizes the used methods.
Table 1 Summary of methods and cell types used in the studies.
Method Cells Publication
2D cell culturing HepaRG, HepG2, H9-GFP, iPS(IMR90)-4, 
WA07
I, II, III, IV
3D cell culturing HepaRG, HepG2, iPS(IMR90)-4, WA07 I, II
Albumin ELISA assay H9-GFP, iPS(IMR90)-4 III, IV
Silica bioreplication HepG2, iPS(IMR90)-4, WA07 II
Conventional PCR HepaRG IV
CYP activity measurement HepaRG, iPS(IMR90)-4 I, IV
CYP induction HepaRG, iPS(IMR90)-4 I, IV
Enzymatic degradation of 
hydrogel
HepG2, iPS(IMR90)-4, WA07 II
Flow cytometry H9-GFP, iPS(IMR90)-4, WA07 II, III
Functional polarity assay HepaRG I
Genomic DNA quantification HepaRG I
Immunostaining HepaRG, HepG2, H9-GFP, iPS(IMR90)-4, 
WA07
I, II, III, IV
Immunohistochemistry HepaRG, WA07 I, II
Confocal microscopy HepaRG, HepG2, H9-GFP, iPS(IMR90)-4, 
WA07
I, II, III, IV
Phase contrast microscopy HepaRG, HepG2, H9-GFP, iPS(IMR90)-4, 
WA07
I, II, III, IV
qPCR HepaRG, H9-GFP, WA07, iPS(IMR90)-4, 
liver tissue, primary human hepatocytes
I, III, IV
Scanning electron 
microscopy
HepG2, iPS(IMR90)-4, WA07 II
Viability assays HepaRG, WA07 I, II
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4.1. Cell culture matrices 
4.1.1 Two-dimensional matrices 
4.1.1.1 Human liver progenitor cell-derived acellular matrix
Human liver progenitor cell-based ACM was prepared from HepaRG cells. The 
human liver progenitor cell line HepaRG was obtained from Biopredict (Gripon et 
al. 2002). The cells were plated at 26,000 cells/cm2 density and cultured for two 
weeks in previously prescribed culture conditions (Aninat et al. 2006; Cerec et al. 
2007). The ACM was prepared with water treatment as described earlier with minor 
modifications and used immediately for plating the cells (Herrema et al. 2006). To 
characterize the matrix composition the ECM protein expression of the HepaRG 
cells was analyzed by conventional PCR and immunofluorescence (see chapters 
4.3.2.2 and 4.3.3.2).   
4.1.1.1 Extracellular matrix proteins
Tissue culture plates were coated with ECM proteins LN-511, LN-521, LN-111, 
collagen type I, collagen type III, fibronectin, or ECM protein mixture Matrigel. LN-
511, LN-521, and fibronectin were used both individually and with seven possible 
combinations. Mouse LN-111 (Cultrex, 25 µg/ml) and rat tail collagen type I (Cultrex, 
50 µg/ml) and human collagen type III (Sigma, 25 µg/ml) solutions were incubated 
in wells for two hours at RT. Human rLN-511 and rLN-521 (Biolamina, 10-20 µg/
ml) and human fibronectin (Sigma-Aldrich, 25 µg/ml) were incubated for two hours 
at 37°C or for overnight at 4°C. Matrigel coating (BD Biosciences) was prepared 
according to manufacturer’s instructions. The LN-511, LN521, and fibronectin 
solutions were collected after use, stored at -20°C, and reused up to two times. 
4.1.2 Three-dimensional matrices 
Plant-derived nanofibrillar cellulose hydrogel, GrowDex®, was obtained from 
UPM-Kymmene Corporation, Finland. The stock hydrogel, typically 1.7 wt% was 
diluted to working concentration of 1.0 wt% with cell culture medium by pipetting. 
Hyaluronan-gelatin (HG) hydrogel, Extracel® (nowadays HyStem®-C), was 
purchased from Glycosan Biosystems (nowadays ESI BIO), and the gel was prepared 
according to the manufacturer’s instructions. HG hydrogel is composed of thiol-
modified hyaluronic acid, thiol-modified gelatin (denatured collagen), and thiol-
reactive crosslinker PEGDA.  
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4.2 Cell cultures
4.2.1 Human liver cell lines
Human hepatocellular carcinoma HepG2 cells (ATCC, HB-8065; Knowles et al. 
1980) were maintained in either in DMEM (Gibco) supplemented with 10% fetal 
bovine serum (FBS), 1 mM L-glutamine, 1 mM sodium pyruvate, 50 U/ml penicillin, 
and 50 µg/ml streptomycin or in high glucose DMEM (Gibco) supplemented with 
10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. HepaRG cells were 
cultured in William’s E medium (Gibco) supplemented with 10% FBS, 50 IU/ml 
penicillin and 50 µg/ml streptomycin, 5 µg/ml insulin, 1 mM L-glutamine and 50 
µM hydrocortisone. 
Both HepG2 and HepaRG cells were maintained in 75 cm2 cell culture flasks in a 
humidified tissue culture incubator at 37°C in 5% CO2. HepG2 cells were passaged 
twice a week and HepaRG cells every two weeks. To promote hepatic maturation, the 
HepaRG progenitor cells were cultured for two more weeks with the presence of 2% 
dimethyl sulfoxide (DMSO) which induces the differentiation towards hepatocyte-
like cells (Gripon et al. 2002).
4.2.2 Human primary hepatocytes and liver tissue
Cryopreserved primary human hepatocytes (BD Biosciences, a 29-year-old female 
donor and a 13-year-old male donor) were recovered by using a cryopreserved 
hepatocyte purification kit (BD Biosciences) according to the manufacturer’s 
instructions. Human liver tissue was obtained from four donors from the 
Transplantation and Liver Surgery Clinic (Helsinki, Finland) which was authorized 
by the National Supervisory Authority for Welfare and Health and by the Hospital 
District of Helsinki and Uusimaa Ethics Committee Department of Surgery. Both 
primary hepatocytes and liver tissue were used as controls in real time polymerase 
chain reaction (RT-PCR).
4.2.3 Human pluripotent stem cells 
The hESC lines WA07 and WA09 (also known as H9) (Thomson et al. 1998) and 
hiPSC line iPS(IMR90)-4 (K. Takahashi et al. 2007; Yu et al. 2007) were purchased 
from WiCell research institute. H9 cells were genetically modified to H9-GFP cells 
as earlier described by us (Lou et al. 2014). The stem cells were cultured in a feeder-
free system using Matrigel as a coating material (BD Biosciences). The mTeSR™1 
medium (STEMCELL™ Technologies) was changed daily. Before cell passaging 
by using Versene 1:5000 (Invitrogen), spontaneously differentiated areas were 
removed by a pipette.
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4.2.4 Hepatic differentiation of human pluripotent stem cells 
The hPSCs were first induced to DE-like cells and then stepwise differentiated 
towards hepatic cells (Figure 4). Protocols for differentiation media were modified 
from earlier reported protocols (D’Amour et al. 2005; Hay et al. 2008; Si-Tayeb et al. 
2010b; Toivonen et al. 2013). The DE cells were plated either on the HepaRG-ACM 
or ECM proteins. Matrigel overlay was used in the last step of the differentiation for 
cells cultured on HepaRG-ACM.
D0 D6 D10 D12-16 D17-21
Act A (100 ng/ml)
*Wnt-3a (75 ng/ml)
*NaBut (1-0.5 mM)
FGF4 (5 ng/ml)
BMP2 (10 ng/ml)
BMP4 (10 ng/ml)
HGF (10 ng/ml)
OSM (10 ng/ml)
DEX (0.1 μM) 
DEX (0.1 μM) 
Endoderm
induction
Hepatic
specification
Hepatic progenitor
expansion
Hepatic
maturation
Transfer of DE cells  
to HepaRG-ACM  
or ECM proteins 
Figure 4 Differentiation protocol of human pluripotent stem cells to hepatocyte-
like cells in vitro. The stem cells were induced to definite endoderm (DE) cells with RPMI-
1640 basal media (Gibco) supplemented with growth factors. After transferring the DE 
cells on studied matrices, the cells were cultured in Hepatocyte Culture Medium (Lonza; 
without rhEGF and gentamicin-amphotericin-1000) with stage specific growth factors. 
*Components used only with H9-GFP cells. ACM, Acellular matrix; Act A, Activin A; BMP, 
Bone morphogenetic protein; DEX, Dexamethasone; ECM, Extracellular matrix; FGF, 
Fibroblast growth factor; HGF, Hepatocyte growth factor; NaBut, Sodium butyrate; OSM, 
Oncostatin M; Wnt, Wingless type.
4.2.5 Three-dimensional cell culturing
The HepG2 and HepaRG cells were first detached with 0.25% or 0.05% Trypsin-
EDTA (Gibco), respectively, and the WA07 and iPS(IMR90)-4 cells with Versene 
1:5000 (Invitrogen). Embedding of the cells to GrowDex hydrogel was performed as 
described earlier by us (Lou et al. 2014; Bhattacharya et al. 2012). Briefly, the liver 
cell suspension was mixed with stock GrowDex hydrogel by pipetting to achieve 1.0 
wt% concentration. The stem cell colonies were gently mixed with 0.5 wt% GrowDex 
hydrogel. Low-retention pipette tips (TipOne®, Starlab Group) were used when 
handling GrowDex. The cells were encapsulated into HG hydrogel according to 
manufacturer’s instructions. 
The HepG2 cells and undifferentiated progenitor HepaRG cells were seeded to 
hydrogels at the density of 1.0 x 106 cells/ml and differentiated HepaRG cells at 
the density of 9.0 x 106 cells/ml. In 3D cultures the stem cell colony density was 
adjusted five-times higher than that in 2D cultures. An equal medium volume to 
hydrogel volume was carefully added on top of the hydrogels.
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4.2.6 Enzymatic degradation of hydrogels
To release the spheroids from the 3D matrices the GrowDex hydrogel was degraded 
with cellulase enzyme (VTT, Turku, Finland) as earlier described (Lou et al. 2014) 
and HG hydrogel with 1 x collagenase/hyaluronidase (StemCell Technologies) 
according to the manufacturer’s protocol. The intact spheroids were recovered from 
GrowDex by incubating them with the cellulase enzyme for 24 hours at 37°C in 5% 
CO2. The spheroids cultured in HG hydrogel could not be released as the enzyme 
digestion broke down the spheroid structure and resulted in single cell suspension.
4.3 Analysis methods
4.3.1 Viability assays 
The cell viability in 3D hydrogel cultures was determined with Trypan blue 
exclusion test, alamarBlue reagent (Invitrogen), or live/dead viability/cytotoxicity 
kit (Molecular Probes) according to the manufacturers’ instructions. The cells 
were exposed to alamarBlue reagent for three hours at 37°C in 5% CO2 and the 
fluorescence of medium samples was recorded with a plate reader (Varioskan Flash, 
Thermo Fisher Scientific). In live/dead assay the cells were treated with calcein-
AM and ethidium homodimer-1 (EthD-1) and imaged with confocal microscope (see 
chapter 4.3.6.2). 
4.3.2 Gene expression
4.3.2.1 RNA isolation and cDNA conversion
Total RNA was extracted from liver tissue with TRI reagent (Sigma Aldrich) 
or RNAlater (Qiagen), and from 2D and 3D cultured cells with TRIzol reagent 
(Invitrogen) or RNeasy Mini kit (Qiagen) according to the manufacturers’ 
instructions. RNA concentrations were measured with a NanoDrop 2000 
spectrophotometer (Thermo Fischer Scientific). The RNA was converted to cDNA 
with a High Capacity RNA-to-cDNA kit (Applied Biosystems) or with RevertAid H 
minus first strand cDNA synthesis kit (Thermo Scientific). The cDNA samples were 
used in conventional PCR and qPCR.
4.3.2.2 Conventional PCR
The gene expression of the ECM proteins in HepaRG cells was studied by 
conventional PCR with a KAPA HiFi HotStart kit (KAPA Biosystems, KK2501). The 
PCR cycles were performed on a DNA Engine Dyad Peltier Thermal Cycler (Bio-Rad 
Laboratories). The PCR cycling conditions included initial denaturation at 95°C for 
5 min followed by 25 cycles of 20 s denaturation at 98°C, 15 s annealing at 60°C and 
30 s extension at 72°C. The PCR cycles were followed by a final extension at 72°C for 
5 min and cooling at 4°C. The PCR products were examined by standard agarose gel 
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electrophoresis and visualized under a UV transilluminator with a CCD camera with 
a motor-operated zoom lens (Syngene Gene Genius Bio Imaging System, Synoptics). 
The size of the PCR products was assessed by comparison with a base pair ladder 
(O’GeneRuler™ Low Range DNA Ladder, SM1203, Fermentas).
4.3.2.3 Quantitative PCR
The cDNA samples were analyzed on a StepOnePlus Real-Time PCR System (Applied 
Biosystems) using Fast SYBR Green Master Mix (Applied Biosystems) or TaqMan 
Universal Master Mix II (Applied Biosystems). The primers were synthesized by 
Oligomer Oy (Helsinki, Finland). Ribosomal protein, large, P0 (RPLP0) and 
cyclophilin G were used as reference genes. The relative mRNA expression was 
calculated either by using relative standard curve or comparative CT-experiment. 
4.3.2.4 Genomic DNA quantification
The cell samples were lysed with RLT buffer (Qiagen) and genomic DNA was 
quantified with Quant-iT™ PicoGreen dsDNA assay kit (Molecular probes). 
Genomic DNA was used to determine the cell proliferation during the culture period 
and to normalize CYP3A4 activity and mitochondrial activity.
4.3.3 Protein expression
4.3.3.1 Flow cytometry
The 2D cultured cells were detached by Cell Dissociation Buffer (Gibco) followed 
by Accutase cell detachment solution (Millipore). The 3D spheroids were first 
recovered from NFC hydrogel with cellulase enzyme treatment (chapter 4.2.6) 
and then disintegrated to single cell suspension with Cell Dissociation Buffer and 
Accutase. Next, the cells were incubated with primary antibodies mouse anti-
SSEA-4 (Developmental Studies Hybridoma Bank), anti-SSEA-3 (STEMCELL™ 
Technologies), or anti-CXCR-4 (R&D Systems). After washing, the cells were 
incubated with APC-conjugated goat anti-mouse IgG (SouthernBiotec), goat anti-
rat IgM (STEMCELL™ Technologies), or goat anti-mouse IgG (Beckman Coulter). 
The negative control samples were treated only with the secondary antibody. The 
samples were analyzed on a BD LSR II flow cytometer using BD FACSDiva software. 
The overlay histograms were created with Flowlogic software.
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4.3.3.2 Immunofluorescence and immunohistochemistry
Protein expression was analyzed by direct immunofluorescence staining from 
2D and 3D cultured cells or from histological sections made from 3D spheroids. 
The staining of whole 3D spheroids was performed either in intact hydrogel 
culture or after enzymatic release in test tubes. The 2D cells were fixed with 4% 
paraformaldehyde (PFA) for 10-15 min and 3D spheroids for 15-30 min depending 
on the spheroid size. Spheroids in HG hydrogel were fixed overnight with 4% PFA. 
Stem cell spheroids and spheroids in HG hydrogel were embedded in paraffin and 
the samples were cut in 5-20µm sections. After deparafinization the sections were 
treated with boiling sodium citrate buffer to retrieve the antigens. 
After fixation, the cell membrane was permeabilized with either 0.1% Triton 
X-100 or 0.5% Saponin for 10-15 min (2D cultures) or for 15-30 min (3D cultures). 
Next, the cells were blocked with 10% normal goat or donkey serum for one hour 
RT or overnight at 4°C. The primary antibodies were incubated with the cells 
overnight. On the following day the cells were incubated with the secondary 
antibodies conjugated with Alexa Fluor 594 (Invitrogen) for one to four hours (2D) 
or five hours (3D). Filamentous actin was stained with Alexa Fluor 594 phalloidin 
(Invitrogen) and cell nuclei with DAPI (Sigma-Aldrich), Hoechst 33258 (Sigma 
Aldrich), or SYTOX green (Invitrogen). Samples on objective glasses were mounted 
with ProLong® Gold antifade reagent (Invitrogen). Stained intact spheroids were 
placed in optical imaging microplate and protected with ProLong® Gold antifade 
reagent or SlowFade® Gold antifade reagent (Invitrogen) before confocal imaging 
(see chapter 4.3.6.2).
4.3.4 Cell functionality
4.3.4.1 Albumin ELISA assay
Secretion of human ALB in cultured cells was determined with Human Albumin 
ELISA Quantitation Set (Bethyl Laboratories) according to manufacturer’s protocol. 
The ALB amount was normalized to total protein content. The cells were lysed with 
1 x RIPA buffer (ThermoFisher Scientific) with 1 x protease inhibitor cocktail (Sigma 
Aldrich) after which the protein amount was measured with a Pierce BCA Protein 
Assay Kit (ThermoFisher Scientific) by following the manufacturer’s instruction.
4.3.4.2 CYP3A4 activity measurement
The activity of CYP3A4 was studied with P450-Glo™ CYP3A4 assay (Promega) 
containing luciferin isopropyl acetate (luciferin-IPA) according to the manufacturer’s 
protocol. The cells were exposed to luciferin-IPA for 60 min at 37 °C in 5% CO2. 
Luminescence was recorded with a plate reader.
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4.3.4.3 CYP3A4 and CYP3A7 induction
The inducibility of CYP3A4 and CYP3A7 enzymes was studied with known inducing 
substrates. The cells were exposed either to dexamethasone, phenobarbital, 
rifampicin, or DMSO. The induction was analyzed with P450-Glo™ CYP3A4 assay 
(see chapter 4.3.4.2) or with qPCR (see chapter 4.3.2.3).
4.3.4.4 Functional polarity assay
Hepatobiliary transport was investigated with fluorescein diacetate (Bravo et 
al. 1998; Barth and Schwarz 1982). The cells were exposed to 10 µM fluorescein 
diacetate and the cell nuclei were stained with Draq5 (BioSatus). The cytoplasmic 
conversion of fluorescein diacetate to fluorescein and its export from cell cytoplasm 
were followed with confocal microscope.
4.3.5 Silica bioreplication
Fixed cells were incubated in a 100 mM tetraethyl orthosilicate (TMOS) solution in 
1 mM hydrochloric acid overnight (2D samples; Kaehr et al. 2012) or for 24–72 hours 
on a shaker (3D samples) at 38°C. HepG2 spheroids in an intact HG hydrogel 
culture were silicified in Lab-Tek® Chamber Slide™ systems in the TMOS solution 
at 38°C for 72 hours. Silicified samples were sequentially washed with nano-pure 
water at pH 3, 1:1 water-methanol solution, and finally 100% methanol and dried in 
air. To study the protein expression in silicified spheroids the samples were treated 
with a dilute, buffered hydrofluoric acid (Transene, TIMETCH) to remove silica. 
The desilicified spheroids were then used for immunostaining (see chapter 3.3.3.2). 
Bioreplicas without the organic material were generated by calcining the silicified 
spheroids in air at 500°C for 16–24 hrs. 
4.3.6 Imaging 
4.3.6.1 Phase contrast microscopy
The cell morphology and growth were followed with phase contrast microscope (Leica 
DM Il LED). Pictures were captured with LAS EZ software (Leica Microsystems).
4.3.6.2 Fluorescence microscopy 
Fluorescent probes were imaged with Leica TCS SP5 II HCS A confocal microscope 
using either HCX PL APO 20×/0.7 Imm Corr (water or glycerol) or APO 0.7 CS 
air objective. DAPI and Hoechst were excited with a UV (diode 405 nm/50 mW), 
calcein, EthD-1, and fluorescein with an argon laser (488 nm/35 mW), Alexa Fluor 
594 with a DPSS (561 nm/20 mW) laser, and Draq5 with a HeNe (633 nm/12mW) 
laser. Emission was acquired with PMT and HyD detectors. The images were 
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analyzed with Imaris program (Bitplane) by creating slice, surpass, or easy 3D 
displays. Immunofluorescence of the H9-GFP cells and their derivatives was imaged 
with a Zeiss Axioplan microscope.
4.3.6.3 Scanning electron microscopy
The 2D and 3D samples were deposited onto either borosilicate cover glasses or 
silicon substrates and sputter-coated with Au/Pd. Scanning electron microscope 
(SEM) images were recorded using an FEI Quanta series scanning electron 
microscope.
4.3.7 Statistical analysis
Statistical significance was determined by one-way ANOVA followed by Holm-
Sidak post-test using SigmaPlot software. Differences of p < 0.05 were considered 
as significant.
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5 Results
The main results of this thesis are briefly presented below and discussed in chapter 
6. The detailed results, including figures, are found in the original publications 
I-IV and in their supplements. The characterized biomaterials used as cell culture 
matrices for in vitro hepatic differentiation are summarized in table 2.
5.1. Three-dimensional matrices promote hepatic differentiation 
and NFC hydrogel enables high-resolution imaging of 3D 
spheroids  
Our aim was to identify a simple 3D cell culture setup from which the formed 3D 
cell aggregates could be easily transferred for high-resolution analysis. First two 
different types of hydrogels, fibrillar wood-derived NFC hydrogel and a hybrid HG 
hydrogel, were tested to create 3D liver organotypic cultures from human liver 
progenitor HepaRG cells. 
Both NFC and HG hydrogels supported the formation of organized multicellular 
aggregates, spheroids, after embedding the cells as progenitors at undifferentiated 
stage (I, Fig. 1 A). When the HepaRG cells were pre-differentiated to hepatocyte-
like cells, they formed clearly less organized spheroids in NFC hydrogel (I, Fig. 1 
B). The spheroid formation in HG hydrogel was approximately the same at both 
differentiation stages.
The 2D and 3D-cultured HepaRG cells were characterized in terms of their 
liver marker expression and hepatic functions. Compared to human liver tissue, 
undifferentiated HepaRG cells in all studied conditions showed similar or higher 
mRNA expression of hepatocyte markers, ALB, MDR1, and MRP2, after two weeks 
of culture (I, Fig. 4A). CYP3A4 expression in 3D-cultured spheroids was nearly at 
the similar level to that of human liver after one week of culture but the expression 
decreased that after (I, Fig. 4A). Similar expression profile in 3D-cultured spheroids 
was observed also with HNF4A, MDR1, MRP2, and with ALB in NFC-cultured cells 
(I, Fig. 4A). However, CYP3A4 activity level in 3D spheroids increased throughout 
the culture showing dissimilar profile to mRNA expression. CYP3A4 enzyme activity 
of HepRG cells embedded in NFC hydrogel increased to a significantly higher level 
compared to cells in HG hydrogel or in 2D culture when the cells were seeded at 
undifferentiated stage (I, Fig. 5 A).     
When the HepaRG cells were seeded to a culture system at differentiated stage, 
the 2D-cultured cells showed the highest HNF4A, ALB, CYP3A4, MDR1, and MRP2 
mRNA expression throughout the culture period (I, Fig. 4 B). In addition, CYP3A4 
activity was the highest in the 2D culture (I, Fig 5B). However, CYP3A4 enzyme was 
inducible with rifampicin, phenobarbital, and DMSO in both 2D and 3D cultures (I, 
Supplement Fig. 1).
After two weeks in culture, the 3D spheroids had formed bile duct-like structures 
with apical MRP2 and MDR1 expression as observed by immunofluorescence 
staining (I, Fig. 6 A). The expression of these transporters were also observed in 2D 
cultures. The functional polarity was confirmed by following canalicular transport of 
45
Supports hepatic 
differentiation of  
hPSC-derived DE cells
Supports hepatic 
differentiation of 
HepaRG cells
Sim
ilarity to liver 
tissue
Batch-to-batch 
variation
Com
m
ercial 
availability
Xeno-free
D
efined com
position
Origin
Type of m
atrix 
in this study
NA
+++
N
FC
 fiber 
diam
eter sim
ilar 
to collagen fiber b
Yes, fiber 
concentration 
can vary
GrowDex®, 
UPM
-Kym
m
ene
Yes
Yes
W
ood pulp
3D
NFC hydrogel 
(I, II)
NA ++
ECM
 
chem
istry 
(HA)
Variations 
negligible d
HyStem
®-C,
ESI BIO
No
Yes
Sem
i-
synthetic
3D HG 
hydrogel 
(I, II)
++ NA
ECM
 
chem
istry
Yes, protein 
content can 
vary
No No
Partially
Hum
an liver 
cell line
2D
HepaRG- 
ACM
  
(III)
-
No DE cell 
attachm
ent
NA
Not expres-
sed in adult  
hum
an liver c
Not known
Cultrex® 
Lam
inin-1, 
Trevigen
No
Yes
M
urine EHS 
sarcom
a 
cells
2D
LN-111  
(III)
+++
NA
ECM
 
chem
istry
No
LN-511™
, 
LN-521™
, 
Biolam
ina
Yes
Yes
Recom
binant 
protein
2D
LN-511 and 
LN-521  
(IV)
-
No DE cell 
attachm
ent
NA
ECM
 
chem
istry
Not known
Cultrex® 
Collagen I, 
Trevigen
No
Yes
Rat tail 
tendons
2D
Collagen 
type I  
(III)
-
No DE cell 
attachm
ent
NA
ECM
 
chem
istry
Variations 
in solubility a
Sigm
a-
Aldrich
No
Yes
Hum
an 
placenta
2D
Collagen 
type III  
(III)
++ NA
ECM
 
chem
istry
Yes, protein 
concentration 
can vary
Sigm
a-
Aldrich
No
Yes
Hum
an 
plasm
a
2D
Fibronectin 
(IV)
-
No DE cell 
attachm
ent
NA
ECM
 
chem
istry 
(- LN-111)
Yes, protein 
content can 
vary
BD 
Biosciences
No
Partially
M
urine EHS 
sarcom
a 
cells
2D
M
atrigel 
(III)
A
C
M
, acellular m
atrix; D
E
, definite endoderm
; E
C
M
, extracellular m
atrix; E
H
S, E
ngelbreth–
H
olm
–
Sw
arm
, H
A
, hyaluronic acid; L
N
, lam
inin;  
N
A
, not analyzed in this thesis; N
F
C
, nanofibrillar cellulose; a, V
ariations anticipated: solubility can vary 10
%
 (Sigm
a-A
ldrich’s technical support 
20
16); b, B
hattacharya et al. 20
12 and Y
. W
ang et al. 20
11; c, K
ikkaw
a et al. 20
0
8
; d, N
o variations in E
C
M
 com
ponent concentrations but degree of 
thiolation can vary (E
SI B
IO
’s technical support 20
16)
Table 2  
Properties of the cell culture m
atrices used in this thesis.
46
fluorescein into formed bile canaliculi-like structures (I, Fig. 7 A). In summary, the 
3D hydrogel cultures promoted faster hepatic differentiation compared to standard 
2D culture but the 3D configuration did not improve the hepatocyte-like properties 
if the cells were differentiated before embedding. 
Next, we examined coupling of the NFC and HG 3D culture systems to high-
resolution imaging to study morphogenesis of 3D cultured cells. We embedded 
human HepG2 liver cells and human PSCs into NFC and HG hydrogels, and 
enzymatically degraded the matrices before analysis. However, we could not 
include the HG hydrogel culture in the future analysis since the hPSCs did not form 
spheroids in it and releasing whole HepG2 spheroids was not possible (II, Fig. 1 A; II, 
Supplementary Fig. 1). Instead, both HepG2 and hPSC spheroids were successfully 
released from the NFC hydrogel with cellulase enzyme. 
We then formed stable cell-silica composites by silica bioreplication (SBR) of 
3D spheroids, which enabled us to follow the growth and morphological changes 
during the culture. The SEM imaging of non-silicified spheroids showed deformed 
and collapsed structures, a dramatic difference compared to silicified spheroids (II, 
Fig. 2 A, B). With SBR, we noticed that HepG2 cells and hPSCs formed tight cell-
cell interactions during the culture period and that cells cultured in 3D format were 
more round than those in 2D culture (II, Fig. 2 B). 
In addition, SBR preserved fine cellular and extracellular structures as shown by 
dense microvilli-like formation on the cell membrane and the ECM-like network 
at the surface of HepG2 cells (II, Fig. 3 A, B). Cellular antigens partially remained 
during the SBR and were detectable by immunofluorescence. In the hPSCs, nuclear 
protein OCT4 was detected before and after SBR in the cell nucleus (II, Fig. 4 A, 
B). However, within HepG2 cells apical protein MRP2 and filamentous actin were 
diffused to cytoplasm during SBR (II, Fig. 4 B). In addition, we showed that all 
organic material of a spheroid can be removed by calcination without destroying the 
microstructures of 3D silica-bioreplica (II, Fig. 3 C). 
In summary, this thesis increases the current knowledge on 3D liver cell culturing 
in hydrogels and describes a new analysis procedure to examine 3D spheroid 
morphology. This work supplements the earlier described NFC cell culture and 
analysis protocols (Bhattacharya et al. 2012; Lou et al. 2014). Taken together, 
NFC hydrogel is a useful culture system to produce intact spheroids for various 
applications and analysis methods (Fig. 5). 
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Figure 5 Nanofibrillar cellulose (NFC) hydrogel culture can be combined with 
multiple analysis methods.  The intact three-dimensional (3D) spheroids can be released 
from the hydrogel by cellulase enzyme treatment. Next, the whole spheroids can be 
analyzed or their structure can be stabilized by silica bioreplication (SBR). Additionally, 
the silicified spheroids can be calcined to create identical silica replicas of spheroids without 
organic material. The released intact spheroids can be transferred into further 3D culture 
systems. In addition, the intact spheroids can be disintegrated into cell suspension by 
enzyme treatment and the single cells can then be either further analyzed or transferred 
into two-dimensional (2D) culture format. The spheroids in NFC hydrogel culture can also 
be analyzed without their release by phase contrast microscope and confocal microscope. 
SEM = scanning electron microscopy; TMOS = tetraethyl orthosilicate.
5.2. Laminin-511 and laminin-521-based matrices support 
hepatic specification of definite endoderm cells
In this project, our aim was to find a stage-specific matrix for hepatic differentiation 
of DE cells. To achieve the goal, we used a three-step approach in which we first 
tested the hypothesis (III), characterized the critical matrix components (IV), and 
developed a defined matrix for hepatic specification (IV).
First, we created ACM from human liver progenitors, HepaRG cell line, to test 
the hypothesis that human liver progenitor-like environment would assist the 
hepatic lineage differentiation. In addition to HepaRG-ACM, we examined other 
commonly used ECM protein-based matrices, including LN-111, collagen type I and 
III, and Matrigel. In the first step of the differentiation the hPSCs, WA07, H9-GFP, 
and iPS(IMR90)-4 cell lines, were induced to DE-like cells. Over 93% of the used 
hPSC lines expressed key pluripotent marker SSEA-3 or SSEA-4 as shown by flow 
cytometry analysis and based on the immunofluorescence staining the cells were 
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positive for OCT4 (III, Supplementary Fig. 1). 
DE-inducing medium was optimized for each cell line as we noticed that similar 
growth factor treatment is not efficient for all the used hPSC lines. After six days of 
ActA, Wnt-3a, and NaBut exposure the H9-GFP-derived cells were highly positive 
for DE markers HNF3B and CXCR-4 (III, Fig. 1 F; III, Fig. 2). The WA07 and 
iPS(IMR90)-4 cells lines were induced to DE-like cells with ActA alone for six days 
after which over 90% and 80% of the cells, respectively, were CXCR-4 positive (III, 
Fig. 1 F). The HNF3B was expressed in the majority of the WA07 and iPS(IMR90)-
4-derived cells (III, Fig. 2). 
The derived DE cells were transferred to the studied matrices, LN-111, collagen 
type I and III, Matrigel, and HepaRG-ACM, and to standard cell culture plastic. 
Other matrices except HepaRG-ACM failed to support attachment and/or growth 
of DE cells (III, Supplementary Fig. 3) and they had to be excluded from the further 
studies. 
The cells transferred to HepaRG-ACM were step-wise differentiated towards 
hepatocytes. The derived progenitors expressed HNF4A, CK-19, and AFP as shown 
by immunofluorescence staining (III, Fig. 4). In the end of the culture, the WA07-
derived cells were positive for HNF4A and partially positive for ALB, CYP3A4, and 
AFP (III, Fig. 5). The iPS(IMR90)-4-derived cells were weakly positive for HNF4A 
and CYP3A4, negative for ALB, and the minority of the cells were positive for AFP 
(III, Fig. 5). The majority of the H9-GFP-derived hepatic cells were positive for 
HNF4A and partially positive for ALB and AFP. 
The cultures overlaid with Matrigel showed decreased AFP and CK-19 mRNA 
expression (in WA07 and iPS(IMR90)-4 cell lines) and induced expression of MRP2 
transporter protein (in H9-GFP cell line) at the end of the differentiation. Increased 
human ALB secretion over the culture period confirmed functional hepatic 
differentiation of H9-GFP-derived cells (III, Supplemenatary Fig. 5). Overall, the 
derived hepatic cells still expressed AFP indicating their immature status and 
the mRNA expression of mature liver markers, ALB and AAT, were greatly lower 
compared to human primary hepatocytes.
In the next step of this work, we characterized the ECM proteins secreted by 
HepaRG cells to be able to replace the ACM with defined ECM proteins. Fibronectin, 
laminin α2, α5, β1, β2 and γ1 chains, and collagen type IV α1, α2 and α5 chains were 
detected at mRNA level (IV, Supplementary Fig. 1). Fibronectin, laminin α5 chain, 
and collagen type IV α2 and α5 chains were also expressed at protein level (IV, Fig. 
1). The  result indicates that HepaRG cells produce fibronectin, LN-511 (composed 
of α5, β1, and γ1 chains), and LN-521 (composed of α5, β2, and γ1 chains) proteins. 
As collagen IV α2 and α5 chains do not form any known heterotrimers collagen 
matrix was not considered for the further studies.
In the final, third step, we tested if we can replicate the effect of HepaRG-ACM 
with the identified HepaRG matrix proteins. The ECM proteins found in human 
progenitor HepaRG cells, LN-511, LN-521 and fibronectin, were used as culture 
matrices for hPSC-derived DE cells. The hPSCs, WA07, H9-GFP and iPS(IMR90)-4, 
expressed the key pluripotent markers OCT4 and/or SSEA-4, and expressed HNF3B 
and CXCR-4 at the DE stage (IV, Supplementary Fig. 2 A, B). The DE induction was 
performed similarly as described above by using different growth factor cocktails 
for H9-GFP cells than to WA07 and iPS(IMR90)-4 cell lines. To identify the optimal 
culture conditions for hepatic differentiation, we screened seven different ECM 
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matrices composed of LN-511, LN-521, and fibronectin, tested different laminin 
concentrations, and optimized the seeding density of DE cells. The used laminins 
were xeno-free recombinant proteins and fibronectin was extracted from human 
plasma. 
We observed that laminins alone support the hepatic specification and that 
fibronectin is not a vital matrix protein for the hPSC-derived DE cells. The hepatic 
specification was efficient on most of the seven studied matrices as shown by high 
expression of the hepatocyte marker HNF4A in the WA07 and iPS(IMR90)-4-derived 
progenitors (IV, Fig. 3). Similarly, the ALB expression in the derived hepatocyte-like 
cells was similar between the studied matrices as shown by immunofluorescence 
(IV, Fig. 4). After screening the seven matrices we did not notice any improvement 
in hepatic differentiation efficacy with the presence of fibronectin. Thus, the 
experiments were continued only with laminins. 
Both  hESC and iPSC-derived hepatic cells cultured on laminin matrices exhibit 
similar morphology to earlier described hESC-derived hepatocytes and increased 
ALB mRNA expression and ALB secretion confirmed their hepatic maturation 
(IV, Fig. 5; IV, Fig. 8; IV, Fig. 7 A; IV, Supplementary Fig. 3 A). Upregulated 
mRNA expression of other liver markers, AAT, CYP3A7, CYP3A4, CYP1A2, and 
glucocorticoid receptor, also indicated the hepatic-lineage differentiation (IV, Fig. 8). 
The mRNA expression of CYP1A2 and CYP3A7 in iPSC-derived cells was comparable 
to the primary hepatocytes (IV, Fig. 8). The hepatic cells cultured on LN-521-based 
matrices showed metabolic enzyme activity as shown by upregulation of CYP3A7 
and CYP3A4 mRNA after dexamethasone treatment (IV, Fig. 7 B). However, the 
induction was not detected at the activity level as measured by CYP3A4 enzyme 
activity. 
In summary, this thesis proves that it is possible to find new stage-specific matrices 
for hepatic differentiation. The work also shows that the desribed three-step 
approach is useful for developing defined culture matrices, and that this approach 
guided us to identify LN-511 and LN-521 proteins for hepatic lineage differentiation 
of DE cells. The workflow to develop defined ECM protein-based 2D matrices is 
illustrated in figure 6.
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• Viability  
• Morphology 
• Cell growth or  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Figure 6 Three-step workflow to develop defined matrices. In the first step, the 
hypothesis is tested by preparing an acellular matrix (ACM) from the cell type of interest 
and using the matrix for plating the cells of interest. If promising results are obtained, the 
extracellular matrix (ECM) proteins secreted by the cells are characterized. Once the ECM 
components are identified, they are tested individually and in combinations for plating the 
cells of interest.   
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6 Discussion
There is an urgent need for functional human hepatocytes in drug development to 
investigate biotransformation pathways and possible hepatotoxicity of a new drug 
candidate (LeCluyse et al. 2012). The viable hepatocytes used in in vitro testing 
can be primary cells derived from human liver, regarded as a golden standard, 
liver cell lines, or differentiated from stem cells (Guillouzo and Guguen-Guillouzo 
2008). In the liver, hepatocytes are in continuous interaction with other cells and 
the surrounding ECM. To create in vivo mimicking cell culture systems, the lessons 
need to be learnt from nature. Many researchers have shown that culturing cells 
with the presence of a biomaterial enables natural cell-cell and/or cell-matrix 
interactions, and thus, improves the viability and functionality of the cells in vitro. 
Indeed, in standard 2D cell culture conditions the tissue-specific structures as well 
as biochemical and mechanical interactions are lost (Pampaloni et al. 2007). Matrix-
based culture systems for hepatocytes have been developed from natural, synthetic 
and hybrid biomaterials and the cells can be grown in 2D or 3D configuration. In 
addition to matrix-based systems, 3D liver cell cultures can be generated using 
bioreactors, microfluidic devices, hanging drop technique, and suspension systems 
with and without stirring (Tong et al. 2016; Griffith et al. 2014; Darnell et al. 2011; 
Y. Takahashi et al. 2015; Higuchi et al. 2016).
Development of novel liver cell culture systems and matrices should start from 
learning from the native liver. In tissue, the complex microenvironment provides 
biochemical and mechanical cues to hepatocytes, blood flow creates shear stress 
and the matrix chemistry and stiffness are not static (Owen and Shoichet 2010; 
Schoen et al. 2001; Abdel-Misih and Bloomston 2010). The in vivo characters of 
liver should guide the design of in vitro cell cultures. On the other hand, the aimed 
use of the cells, available materials and devices, as well as time and cost, also play 
a part in developing cell culture models. Besides the biological understanding, 
the development of new culture systems requires new materials and/or devices 
for building the models, and finally new analysis techniques for monitoring the 
advanced systems. 
6.1 Mimicking liver tissue in a dish with bioinspired matrices
New bioinspired matrices can be generated by modifying existing natural materials 
or synthesizing novel materials based on the idea from nature (Smitthipong et 
al. 2014). Mimicking native tissue in a dish can be approached by simulating the 
stiffness, ECM chemistry, shear stress, or the structure of the liver. In this thesis, NFC 
hydrogel, HG hydrogel, HepaRG-derived ACM, LN-511, LN-521, and fibronectin 
were used as culture matrices for human hepatic cell lines or to differentiate hPSCs 
towards hepatocyte-like cells (I, II, III, IV; Table 2). 
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6.1.1. Three-dimensional hydrogels induce differentiation of liver cells 
3D cell culture matrices were already introduced over 40 years ago (Elsdale and 
Bard 1972). Hydrogels are attractive biomaterials for 3D cell culturing since they 
can be made from a wide range of natural or synthetic polymers and their fibrous 
structure mimics the native ECM fibers to some extent (Tibbitt and Anseth 2009). 
Despite their popularity, hydrogels have not been widely used for culturing human 
liver progenitor HepaRG cells this far (Bhattacharya et al. 2012; Colosi et al. 2014; 
Dianat et al. 2014). Other described 3D culture formats for HepaRG cells include 
tethered spheroid culture, bioreactor, hanging-drop system, a micropatterned 
agarose substrate, and a suspension culture with a presence of aggregation inhibiting 
polymer (Z. Wang et al. 2015; Y. Takahashi et al. 2015; Darnell et al. 2011; Mercey 
et al. 2010; Higuchi et al. 2016). HepaRG is a bipotent cell line that can differentiate 
to hepatocyte-like cells and cholangiocyte-like cells (Cerec et al. 2007). Compared 
to other existing liver cell lines, differentiated HepaRG cells are functionally more 
similar to primary human hepatocytes (Lübberstedt et al. 2011; Kanebratt and 
Andersson 2008; Hart et al. 2010). In addition, HepaRG cells have already been 
used for testing acute and long-term toxicity (Mueller et al. 2014; Leite et al. 2012). 
We showed that 3D hydrogel culture induced the differentiation of HepaRG 
progenitor cell line to organotypic 3D spheroids with functional bile duct-like 
structures (I). We noticed that NFC hydrogel promotes rapid differentiation of 
HepaRG cells as indicated by gene expression of typical liver markers. Thus, 
functional studies could be performed in the future after a one-week culture period 
to investigate if the 3D cultured cells could be used, for example, for drug testing 
one week earlier than the typical two-week culture time. The metabolically active 
organoids might serve a useful liver model in drug development for substance 
testing. However, the replacement of standard 2D cell cultures with 3D culturing in 
the pharmaceutical industry will still take time (Rimann and Graf-Hausner 2012). 
On the other hand, once the reproducibility and higher throughput with reasonable 
cost are achieved, the 3D cell culture technologies will likely become more common 
in drug and chemical testing.  
Mechanical properties of liver tissue change during its development and vary 
between regions of the liver (Lozoya et al. 2011). The stiffness of the culture matrix 
has shown to also affect hepatic cell fate in vitro (Lozoya et al. 2011; Hamilton et 
al. 2001). Lozoya et al. (2011) described that stiffness of the HA hydrogel plays an 
important role in the hepatic differentiation. They reported that a hydrogel with a 
stiffness of 73-220 Pa induced the differentiation of hepatic stem cells to hepatic 
progenitors the best. Much stiffer HA hydrogels were suggested for culturing primary 
human hepatocytes (Deegan et al. 2015). Deegan et al. reported that the stiffness 
between 1200-4600 Pa is optimal for maintaining primary hepatocyte functions. 
The reported stiffness values of normal liver vary from 2 to 7 kPa   (Rouvière et al. 
2006; Roulot et al. 2008). We did not measure the stiffness of HG hydrogel but 
according to earlier reports it is below 100 Pa (Vanderhooft et al. 2009). The storage 
modulus of the other studied biomaterial, 1.0 wt.% NFC hydrogel, is approximately 
100-200 Pa (Pääkkö et al. 2007; Harjumäki et al. unpublished). Despite the fact 
that the stiffness of the studied hydrogels is one magnitude less compared to those 
recorded from liver, the hydrogels successfully induced liver functions in HepaRG 
spheroids (I). However, the comparison of reported stiffness values is not fully 
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reliable if the analysis method is not exactly the same.
The trends in the field of hydrogel research have been shown to shift from using 
simple polymer networks to using smart, functional gels (Buwalda et al. 2014). 
Indeed, the fourth dimension, control over time, has already been introduced in cell 
culturing (Tibbitt and Anseth 2012). The mechanical properties of NFC hydrogel 
could be varied during the culture by increasing or decreasing fiber concentration, and 
future studies could include a careful screening of different hydrogel concentrations 
to analyze if the varying stiffness affects hepatic differentiation of HepaRG spheroids. 
It would be especially interesting to study if a stiffer NFC hydrogel than the tested 1.0 
wt.% would support the maintenance of differentiated status of HepaRG cells. We 
observed that the expression of hepatocyte markers decreased when the cells were 
embedded into hydrogels at differentiated state (I). We have not studied the reason 
for this but it could be due to the fact that the spheroids seeded at differentiated 
state were less polarized than the spheroids embedded at undifferentiated state 
as observed by immunofluorescence and functional polarity assay. In the future, 
further studies with NFC could also include functionalization of the hydrogel. 
Dissimilarly to HG hydrogel, NFC hydrogel does not provide biochemical cues to 
cultured cells as it does not contain any ECM components. 
In general, NFC hydrogel is an interesting new xeno-free biomaterial already tested 
for a few other biomedical applications including wound care and drug delivery 
(Kolakovic et al. 2012; Mertaniemi et al. 2016; Laurén et al. 2014). NFC hydrogel 
has structural similarities to ECM in liver. Cellulose nanofibers of NFC hydrogel 
are 20-30 nm in diameter on average and several micrometers in length, which are 
similar characteristics to those of native collagen fibers in the liver (Bhattacharya et 
al. 2012; Y. Wang et al. 2011). Compared to other commercial hydrogels, the most 
significant advantage of NFC hydrogel is that it can be degraded with a specific 
enzyme to release viable spheroids for further analysis or culture (Lou et al. 2014; 
discussed more in chapter 6.2). A disadvantage of the product is its tendency to 
adhere on plastic surfaces, and thus, special low retention pipette tips are required 
for its dispensing. In addition, when working with low fiber concentration, for 
example with 0.5 wt.% NFC, which is optimal for hPSCs (II; Lou et al. 2014), the 
hydrogel is very loose and changing of cell culture media is challenging.   
6.1.2 Lineage-specific matrix guides efficient hepatic differentiation
Human PSCs have gained a solid foothold in basic research but also in the drug 
industry as they have potential to offer a limitless supply of various somatic cell 
types needed in drug development (Grskovic et al. 2011). Differentiation of hESCs 
and hiPSCs to hepatocyte-like cells has been studied extensively (Duan et al. 2010; 
Si-Tayeb et al. 2010b; Hay et al. 2008; Cai et al. 2007). However, the scientific 
community still faces the major challenge in the differentiation process; derived 
hepatic cells are immature and their phenotype is closer to fetal hepatocytes than 
mature cells (Schwartz et al. 2014; Baxter et al. 2015). In the majority of the published 
protocols, hPSCs are guided towards hepatocytes with growth factors through DE 
stage (Baxter et al. 2015; Gerbal-Chaloin et al. 2014). Indeed, during embryogenesis 
the cells from definitive endoderm differentiate to fully functional adult hepatocytes 
under specific biochemical and mechanical cues (Zaret 2001). 
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Growth factors commonly introduced to hPSCs to differentiate them to DE-like 
cells in vitro include Activin A, Wingless-related integration site 3A, and, sodium 
butyrate (D’Amour et al. 2005; Hay et al. 2008; Toivonen et al. 2013). At the next 
step of differentiation, the hepatic specification is induced with fibroblast growth 
factor and bone morphogenetic proteins 2 and 4 (Schwartz et al. 2014; Hannan 
et al. 2013). To mature the derived cells, culture media can be supplemented with 
hepatocyte growth factor, oncostatin M, and dexamethasone (Hannan et al. 2013; 
Si-Tayeb et al. 2010b; Hay et al. 2008). Besides growth factors, small molecules 
have been proposed for priming hPSCs for hepatic differentiation (Zhu et al. 2009) 
or they can be applied in each of the differentiation steps (Tasnim et al. 2015). The 
use of soluble factors in the hepatic differentiation protocols have been a clear focus 
as they are commercially available and can be easily added into the culture media. 
However, it is recognized that not only soluble factors but also cell-cell interactions 
and cell-matrix interactions play an important role in the complex, multistage cell 
differentiation process (DiPersio et al. 1991). One route to improve the in vitro 
culture systems is to learn from the ECM cues in vivo, an approach which was 
successfully demonstrated in this thesis (III, IV). 
At the moment, the optimal culture matrix for in vitro hepatic differentiation of 
the DE cells is poorly understood. A careful analysis of a target tissue can lead to 
the design of new biomaterials. It has been suggested that a systematic examination 
of ECM components and their localization in decellularized liver could guide 
the development of new matrices and engineered culture systems for liver cells 
(Ananthanarayanan et al. 2011). We hypothesized that ECM produced by human liver 
progenitors would induce efficient hepatic specification. In hepatic differentiation, 
the DE cells commit first to hepatic progenitors and thus we aimed to create a 
progenitor-specific matrix to assist the hepatic lineage differentiation of DE cells. 
To test the hypothesis, we created an ACM from human liver progenitor HepaRG 
cells and plated hPSCs-derived DE on the ACM. Indeed, we were able to show that 
HepaRG-ACM supports attachment of DE cells derived from three different hPSC 
lines, and also, their hepatic differentiation (III). Cell sheet-derived ACMs are cost-
effective but also a laborious approach to produce matrices. In addition, their ECM 
protein content can vary between batches. Therefore we analyzed the HepaRG-ACM 
proteins in order to study if the effect of HepaRG-ACM can be achieved with defined 
ECM proteins.
After a comprehensive screening of the ECM proteins secreted by HepaRG cells, 
fibronectin, LN-511, and LN-521 were identified (IV). Collagen type IV α2 and α5 
chains were also detected in HepaRG-ECM but as they cannot assemble a known 
collagen protein we did not include collagen type IV in our experiments. The three 
identified ECM proteins were then used for plating DE cells individually and with all 
their possible combinations to study if they can replicate the effect of HepaRG-ACM. 
All the studied matrices supported the attachment of hPSC-derived DE cells and the 
cells were successfully differentiated towards hepatic cells expressing typical liver 
markers (IV). Unexpectedly, the differentiation efficacy on defined matrices was 
even higher compared to ACM (III, IV). This might be due to a loss of ECM proteins 
during the decellularization process of HepaRG before plating the DE cells. 
Laminins have lately aroused interest as cell culture matrices for hepatic 
differentiation of hPSCs (Vuoristo et al. 2013; Takayama et al. 2013; Takayama et 
al. 2014; Cameron et al. 2015). In the adult liver, LN-511 and LN-521 are expressed 
55
in periportal area which is suggested to hosts the most immature hepatic-lineage 
cells (Kikkawa et al. 2008; Turner et al. 2011). Recently, Cameron et al. (2015) used 
recombinant laminins, LN-521 and LN-521/LN-111 mixture, for plating hPSCs and 
induced them to hepatocyte-like cells via DE stage. In our study, we seeded the hPSC-
derived DE cells to a hepatic progenitor-like environment to provide a stage-specific 
matrix to guide their differentiation to progenitors. Interestingly, we observed that 
only LN-511 and LN-521 but not LN-111, support the attachment of DE cells (IV 
and III, respectively). In addition, the cells failed to attach to surfaces coated with 
collagen types I and III and Matrigel (III). Matrigel does not contain LN-511/521 
which might explain why it inhibited the DE attachment. Matrigel is widely used for 
culturing many cell types including hPSCs, also in our study. However, during the 
DE differentiation on Matrigel the cells can remodel the matrix and also, the ECM in 
the culture well is dissimilar to the original coating substratum. This could explain 
why the DE cells cultured on Matrigel did not attach to fresh Matrigel coating. 
However, further studies on ECM expression should be performed to confirm this 
hypothesis. Collagen type III is expressed in zone 1 like laminins (McClelland et 
al. 2008), but failed to support the attachment of DE cells (III). Fibronectin, alone 
and when combined with laminins, supported both the attachment and hepatic 
differentiation of DE cells (IV). However, as fibronectin is not a liver specific ECM 
protein and we did not observe improvement in the cell differentiation efficacy with 
its presence, we did not include fibronectin in our later studies.
The described HepaRG-ACM, LN-511 and LN-521-based matrices showed 
promising results in terms of efficient hepatic specification (III, IV). The derived 
progenitors highly expressed transcription factors HNF4A, AFP, and CK-19 (III, 
IV). In regenerative medicine, there has been increased interest in using hepatic 
stem/progenitor cell therapies to treat liver damage (Cardinale et al. 2014; Fausto 
2004). Recombinant LN-511 and LN-521 would provide an ideal matrix for obtaining 
hepatic progenitor cells from hPSCs as they are GMP-grade xeno-free reagents. To 
use the derived hepatic cell in the clinics, our protocol should be further modified 
so that it would only contain xeno-free reagents in each culture step. For drug and 
chemical testing, the matrix and cell culture media do not have such limitations but 
the derived cells should not exhibit batch-to-batch variations. The use of defined 
matrices can be helpful to reduce variability between the cultures. During the 
protocol development we optimized the LN-511 and LN-521 coating concentration 
to improve the differentiation efficacy as the density of ECM proteins is known to 
regulate the cell fate (Owen and Shoichet 2010). Other optimized parameters to 
improve hepatic maturation were plating density of DE cells, culture period, growth 
factor combination for DE induction for each hPSC line, and we also tested Matrigel 
overlay at the end of the differentiation (III, IV). 
Finally, we demonstrated that LN-511 and LN-521 promote the hepatic 
specification of both hESC and hiPSC-derived DE-cells. In this study we did not 
compare the differentiation efficacy to any known protocol in our laboratory and 
that could be done in the future. On the other hand, the control culture would have 
to be performed in a different way since the DE cells did not survive on any other 
of the tested matrices than LN-511, LN-521, and fibronectin. The control culture 
system, for example culturing the hPSCs on Matrigel wihthout the detachment step, 
would let us compare the end product of the differentiation, derived-hepatocytes, 
but it would not reveal new information about the specific matrix for DE cells. In our 
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study, the derived cells increased their ALB secretion over the culture period and 
exhibited metabolic activity confirming their hepatocyte-like status (IV). However, 
they were phenotypically closer to fetal hepatocytes instead of mature hepatocytes. 
Thus, the culture protocol should be further modified to obtain more matured cells. 
Possible strategies to improve the culture condition could include exposing the cell 
monolayer to flow in a flat bioreactor, creating a co-culture system, or transfer the 
cells into matrices composed of zone 3 proteins, such as collagen type I and IV, after 
reaching the fetal hepatocyte-like status (Ordovás et al. 2013; Gieseck et al. 2014; 
Takebe et al. 2013). 
It is clear that ECM chemistry has an important role in guiding hepatic 
differentiation in vivo and in vitro. ECM secretion already starts at the embryonic 
stage, and throughout the development ECM has an essential function in regulating 
cell functions and maintaining the tissue homeostasis (Rozario and DeSimone 
2010; Badylak et al. 2015). In the liver, the ECM chemistry exhibits gradients from 
zone 1 to zone 3. Learning from these ECM gradients can help us to identify novel 
biomaterials for hepatic differentiation. Our study serves as an example that it was 
possible to identify new hepatic lineage stage specific biomaterials by characterizing 
the ECM proteins of the liver progenitor cells. This approach can be applied to find 
other new matrices for other specific lineage stages in the liver or in other tissue. 
6.2 Multidimensional cell cultures require advanced analysis 
techniques
To record the data from advanced 3D cell culture systems, special analysis 
techniques are required (Pampaloni et al. 2007). Imaging of 3D spheroids and 
tissue samples is especially challenging due to the thickness of a specimen. When the 
cells are cultured within a biomaterial the matrix can also hamper or even prevent 
the analysis. For example, for single-cell-based assays such as flow cytometry the 
cultured 3D spheroids need to be released from the matrix and disintegrated into 
single cell suspension. 
Even though there are numerous biomaterials described for cell culturing, only 
a few of them are optimal for analysis of 3D spheroids. Some of the commercial 
hydrogels can be enzymatically degraded enabling more downstream analysis of 
the cells. We cultured hPSCs and HepG2 cells in HG hydrogel, composing of HA, 
gelatin and PEGDA, to study the 3D structure of the cells. However, the enzymatic 
degradation of HG hydrogel with collagenase/hyaluronidase, as recommended 
by the manufacturer, destroyed the spheroid structure and thus prevented the 
analysis (II). We hypothesized that spheroid disintegration during collagenase/
hyaluronidase treatment might have been caused by a cleavage of collagen and HA 
which were possibly formed by the cells to stabilize the spheroid structure. However, 
we have not studied the presence of ECM proteins in the spheroids cultured in HG 
or NFC hydrogel by staining or PCR. Nonetheless, we have observed an ECM-like 
network formed around the spheroids cultured in NFC hydrogel (II). The analysis of 
ECM proteins produced by the spheroids could be performed in the future. 
Numerous natural, synthetic, and hybrid biomaterials have been proposed for 3D 
cell culture. However, hydrogels which allow release of whole 3D spheroids have 
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rarely been described. D. Wang et al. (2011) introduced a thermoreversible hydrogel 
from which the intact spheroids can be recovered by incubating the plate at room 
temperature. The group encapsulated HepG2 cells in thermosensitive poly(N-
iso-propylacrylamide) in situ by increasing the temperature to 37°C at which the 
gelification occurred immediately. The spheroids were released by incubating the 
culture at 25°C for four hours in total. The described protocol might be applicable 
for strong cell lines such as HepG2 but could not be used for sensitive cells such as 
stem cells without decreasing their viability or causing unwanted differentiation. 
The most prominent feature of NFC hydrogel is that viable intact spheroids can 
be released from the culture matrix. Plant-derived NFC is composed of fibers that 
are formed from aligned β-D-glucopyranose polysaccharide chains (Bhattacharya 
et al. 2012; Pääkkö et al. 2007). Our group showed earlier that NFC hydrogel can be 
degraded with cellulase enzyme without interfering with the viability, structure, or 
pluripotency of 3D hPSC spheroids (Lou et al. 2014).  
Stabilizing architecture of 3D spheroid for detailed morphological examination 
has turned out to be challenging. Inspired by single cell silicification demonstrated 
by Kaehr et al. (2012) we tested if the 3D structure of spheroids can also be preserved 
to more closely study the morphology of 3D organized cells. Indeed, we showed that 
SBR is a powerful technique to maintain the intact spheroid architecture, fine cellular 
structures, and also cellular antigens (II). We combined SBR with SEM imaging 
for detailed morphological examination of 2D and 3D cultured hPSCs and HepG2 
cells. In addition, we showed that all organic cellular material can be removed by 
high temperature calcination to create identical silica replica of a spheroid. SBR 
could possibly be combined with other analysis techniques as well, or production of 
silica replicas could be used to develop highly detailed biomimetic materials as also 
suggested by Townson et al. (2014).
Releasing 3D spheroids from the culture matrix is beneficial for confocal 
microscope imaging. We demonstrated that the spheroids recovered from the NFC 
hydrogel can be imaged as whole-mount samples or sectioned prior to histological 
analysis (I, II). Optionally, the spheroids, fixed or living, can be stained and imaged 
inside the NFC hydrogel (I). However, the resolution of the acquired images is 
lower when the spheroids are inside the NFC matrix which is most likely due to 
light scattering from the fibers. In addition, penetration of the antibodies might 
be decreased in the hydrogel. Lastly, the thickness of a whole-mount specimen 
itself causes challenges in their analysis and is commonly the limiting factor in 
imaging (Pampaloni et al. 2007). Significant advances in 3D imaging have been 
obtained with light sheet fluorescence microscopy (LSFM) that is applicable for 
thick samples, both fixed and living (Pampaloni et al. 2015). In the future, LSFM 
imagining could be used to analyze intact 3D hPSCs generated in NFC hydrogel. 
The diameter of hPSC spheroids can exceed several hundred micrometers and with 
confocal microscope imaging the inner cell mass of whole mount spheroids cannot 
be detected well. Our group has overcome this challenge earlier by sectioning the 
spheroids, however LSFM would enable analysis of the whole spheroid. 
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7 Conclusions
Mimicking liver environment in a dish can be approached from various angles. The 
native liver can best be resembled by using whole liver ACMs, liver chemistry by 
ECM proteins, liver structure with fibrillar materials or scaffolds, and liver stiffness, 
for example, with hydrogels. Indeed, complexity of the liver cannot be captured with 
standard, simple 2D cell culture techniques. The matrices studied in this thesis, the 
HepaRG-ACM, LN-511, and LN-521, liver ECM component-based biomaterials, 
NFC hydrogel, an artificial liver-mimicking biomaterial, and HG hydrogel, hybrid 
biomaterial, are promising materials to differentiate hepatic cells in vitro (I, III, IV). 
In addition, this thesis demonstrates a new workflow to find new biomaterials and 
to develop defined matrices (III, IV). For morphological examination of complex 3D 
constructions, this thesis suggests a straightforward protocol that uses NFC hydrogel 
as culture matrix and SBR to preserve intracellular and extracellular structures of 
the spheroids (II). In summary, this thesis describes new bioinspired matrices for 
hepatic differentiation in vitro, a protocol to analyze complex spheroid morphology, 
and that the described three-step approach can guide the identification of new ECM 
protein-based cell culture matrices.   
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